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Abstract: The synthesis is reported of a series of blue-emitting heteroleptic iridium complexes with 
phenylpyridine (ppy) ligands substituted with sulfonyl, fluorine and / or methoxy substituents on the 
phenyl ring, and a picolinate (pic) ancillary ligand. Some derivatives are additionally substituted with a 
mesityl substituent on the pyridyl ring of ppy to increase solubility. Analogs with two ppy and one 2-
(2’-oxyphenyl)pyridyl (oppy) ancillary ligand have been obtained by an unusual in situ nucleophilic 
displacement of a fluorine substituent on one of the ppy ligands by water followed by N^O chelation 
to iridium. The X-ray crystal structures of seven of the complexes are reported. The photophysical and 
electrochemical properties of the complexes are supported by density functional theory (DFT) and 
time dependent DFT (TD-DFT) calculations. Efficient blue phosphorescent organic light-emitting 
devices (PhOLEDs) have been fabricated using a selection of the complexes in a simple device 
architecture using a solution-processed single-emitting layer in the configuration 
ITO/PEDOT:PSS/PVK:OXD-7(35%):Ir-Complex(15%)/TPBi/LiF/Al. The addition of a sulfonyl 
substituent blue shifts the electroluminescence by ca. 12 nm to max
EL
 463 nm with CIEx,y coordinates 
0.19, 0.29, compared to the benchmark complex FIrpic (max
EL
 475 nm, 0.19, 0.38) in directly 
comparable devices, confirming the potential of the new complexes to serve as effective blue dopants 
in PhOLEDs.  Replacing a fluorine by a methoxy group in these complexes red shifts the PL and EL 
max by ca. 4-6 nm. The efficiency of the blue PhOLEDs of the sulfonyl-substituted complexes is, in 
most cases, significantly enhanced by the presence of a mesityl substituent on the pyridyl ring of the 
ppy ligands. 
Introduction 
Luminescent transition metal complexes are widely exploited in many areas,
1
 such as biological 
labelling probes, ion sensors, water splitting, solar cells, and phosphorescent emitters for organic light-
 2 
emitting diodes (OLEDs)
2,3,4,5,6,7, 8
 and for solid-state lighting.
9,10
 In the OLED and lighting field 
cyclometalated iridium(III) complexes have received special attention because they can harvest both 
singlet and triplet excitons, leading to internal quantum efficiencies approaching 100%. 
11,12,13
 Key 
features of the complexes include their synthetic versatility, good color tuneability, generally good 
chemical and photochemical stability, relatively short excited state lifetimes on the microsecond 
timescale, and highly efficient emission from a mixture of triplet metal-to-ligand charge-transfer 
(MLCT) states and * transitions of the ligands.14 Tris-homoleptic complexes [Ir(C^N)3], where 
C^N is a monoanionic bidentate ligand, have been extensively studied, e.g. the prototype green emitter 
fac-Ir(ppy)3 (ppy = 2-phenylpyridine).
2
 The highest occupied molecular orbital (HOMO) is primarily 
localized on the phenyl  and iridium d orbitals, while the lowest unoccupied molecular orbital 
(LUMO) resides mainly on the pyridine ring. Electron-withdrawing substituents, typically fluorine, are 
attached to the phenyl ring of the ppy ligands to blue shift the emission by lowering the HOMO energy 
without significantly changing the LUMO energy.
15,16 
For heteroleptic complexes [Ir(C^N)2L] the 
ancillary ligand L can also be used to tune the emission color. The complex iridium(III) bis[4,6-
(difluorophenyl)pyridinato-N,C 2′]picolinate (FIrpic 1) (Figure 1) is the benchmark sky-blue emitter 
for phosphorescent OLEDs (PhOLEDs).
17,18,19,20,21,22
 Other structural modifications which give blue 
emission involve different ancillary ligands such as N-heterocyclic carbenes,
23
 pyridylazolate 
derivatives,
24
 fluorine-substituted bipyridine chelates
25
 and dicyclometalated phosphate tripod 
ligands.
26
 The motivation for the present work was provided by the high level of ongoing research to 
develop new blue-emitting phosphors.
27,28
  
 This article describes the synthesis, X-ray structural and optoelectronic characterization of a 
systematic series of analogs of FIrpic 1 in which the phenyl ring bears a sulfonyl substituent at the C3 
position to further lower the HOMO energy and blue shift the emission. Additionally, we report 
derivatives with one or both of the fluorine atoms at C2 and C4 replaced by a methoxy group. The 
rationale here is that substituting one fluorine with an alkoxy group is known to have a minimal effect 
on the emission color while increasing the chemical stability of the complex to unwanted nucleophilic 
substitution reactions
29 , 30
 during, or after, complex formation.
31
 It is also known that di/multi-
fluorinated ligands can degrade during OLED operation.
32
 In some of the complexes a mesityl 
substituent is attached to C4 of the pyridyl ring, as it has been reported that this functionalization leads 
to enhanced PhOLED efficiency,
33
 which is also the case for several complexes in the present work. 
The experimental photophysical and electrochemical data are supported by time-dependent density 
functional theory (TD-DFT) calculations. Blue PhOLEDs have been fabricated with selected 
complexes as the emitter. 
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Figure 1. Structure of FIrpic 1 
 
Results and Discussion 
It has been established previously that functionalizing the phenyl ring of FIrpic 1 with an 
electron-withdrawing group at C3 (i.e. between the two F atoms) induces a blue shift in emission: 
examples are cyano,
34
 sulfonyl,
35e
 phosphoryl,
35e
 and perfluoroalkyl carbonyl substituents.
24b
 The 
present work focuses on sulfonyl groups, which have only rarely been incorporated as substituents on 
C^N cyclometallating ligands in either neutral
35
 or ionic
36
 complexes. With the exception of complex 
11, which has been reported previously by Fan et al using a different method to introduce the p-
toluenesulfonyl substituent,
35e
 to our knowledge the sulfone-containing complexes studied in this work 
have not been synthesized previously. The synthetic routes to complexes 10-15, 23-25 and 31 are 
shown in Schemes 1-3. All the complexes are characterized by NMR spectroscopy, mass spectrometry 
and elemental analysis, with additional single crystal X-ray crystallographic data for seven of the 
complexes.  
 The key step to introduce the sulfone substituent involves lithiation of 2-(2,4-
difluorophenyl)pyridine 2
37
 or the mesityl analog 3 with LDA, followed by iodination to yield 4 and 5 
and then reaction with either sodium p-toluenesulfinate or sodium methylsulfinate in the presence of 
stoichiometric copper(I) iodide, to afford ligands 6-8 in 15-26% yields (Scheme 1). These yields were 
highly reproducible in several reactions and could not be improved by ultilising a copper(II) 
bis(arylsulfinate) reagent,
38
 or a CuI/L-proline system,
39
 or ionic liquid additives.
40
 On one occasion, 
when using a batch of 4 that had not been rigorously purified (and was probably contaminated with 
iodine from the previous reaction) the di(methanesulfonyl) derivative 9 was also isolated in 11% yield 
alongside product 6. When the reaction was repeated with rigorously purified 4 and the addition of a 
trace of iodine, compound 9 was again obtained in very low yield. Exploring the mechanism of this 
reaction is outside the scope of this work. However, it can be postulated: (i) that iodine coordinates to 
the pyridyl N atom of ligand 4 or 6, to form a more electron-withdrawing pyridinium unit, thereby 
further increasing the reactivity (by increased electron deficiency) of the phenyl ring, or (ii) that a 
fluorine in ligand 4 or 6 is replaced by iodine prior to the reaction with the methylsulfinate anion. 
 4 
There is precedent for a combination of fluoro and iodo substituents on a phenyl ring facilitating SNAr 
reactions at a C-F bond.
41
    
 The synthesis of methoxy analogs 23-25 followed a similar protocol starting from 
phenylpyridine derivatives 16 and 17, which were readily obtained by standard Suzuki reactions of the 
commercially-available 1-fluoro-3-methoxyphenylboronic acid (Scheme 2). Notably, the conversions 
of 18 and 19 to yield methanesulfonyl derivatives 20 and 21 proceded in significantly higher yields (45 
and 53%, respectively) than the comparable reactions of the difluoro analogs 4 and 5 in Scheme 1. 
However, the yield of p-tolyl derivative 22 is still low (21%).  
 To explore the effect of replacing both fluorine atoms with methoxy substituents, complex 31 
was synthesized. To obtain the dimethoxy ligand 30, a different synthetic approach was used starting 
from the known compound 26
42
 (Scheme 3). In this case, the sulfone functionality was obtained by 
oxidation of the methylthio group of 29 with meta-chloroperbenzoic acid in 83% yield.  
 To obtain the picolinate complexes 10-13, 23-25 and 31 standard conditions were employed;
43
 
namely, reaction of the ligand with IrCl3·3H2O (or [Ir(cod)Cl]2 for 31) in 2-ethoxyethanol to give a 
presumed bridged μ-dichloro diiridium species [Ir(L)2Cl]2 which was reacted in situ with picolinic 
acid. Attempts to isolate the intermediate dimer species were unsuccessful in most cases and usually 
led only to unidentified decomposed products. The attempted synthesis of 31 using IrCl3·3H2O failed 
to yield any product and the ligand 30 could not be recovered. Difficulties in the cyclometalation of 
ligands containing methoxy substituents using IrCl3·3H2O have been reported previously.
30b 
 Attempts to form the corresponding tris-cyclometalated homoleptic [Ir(C^N)3] complexes from 
6 and 7 using established conditions,
31d
 by adding more C^N chelate to the [Ir(L)2Cl]2 species, gave 
the unexpected and unusual [Ir(C^N)2(N^O)] complexes 14 and 15 in 29% and 23% yields, 
respectively. There was no sign of the homoleptic complexes after purification of the product mixture. 
The structures of 14 and 15 were tentatively assigned based on mass spectra combined with 
19
F NMR 
spectra which showed the presence of only five fluorine atoms, together with 
1
H NMR and COSY 
spectra which established that a fluorine ortho to a pyridyl group had been replaced on one of the 
ligands. The structures were subsequently unambiguously confirmed by X-ray crystallography of 15 
(see below). The phenyl ring of ligands 6 and 7 is highly electron deficient due to the presence of 
pyridyl, fluorine and sulfone substituents, therefore, an SNAr reaction at a C-F bond is entirely 
reasonable, for example reaction with residual water in the ethylene glycol sovent, with subsequent 
N^O chelation as a 2-(2’-oxyphenyl)pyridyl (oppy) ancillary ligand. We are not aware of a previous 
example of an Ir complex of an oxyphenylpyridyl ligand. Indeed, 6-membered ring chelation to Ir with 
a bidentate N^O ancillary ring appears to be very rare:
14b
 related examples include [Ir(C^N)2(N^O)] 
structures with two ppy ligands and 2-(2’-oxyphenyl)oxazole44 or 2-(2’-oxyphenyl)oxazoline45 as the 
ancillary N^O ligand.  
 5 
  
Scheme 1. Synthesis of complexes 10-15. Reagents and conditions: i, LDA, THF, -78 
o
C, I2, THF, 20 
o
C; ii, NaMeSO2 or Nap-TolSO2, CuI, DMF, 110 
o
C; iii, NaMeSO2, CuI, I2, DMF, 110 
o
C; iv, 
IrCl3·3H2O, 2-ethoxyethanol, 130 
o
C, followed by picolinic acid, 130 
o
C; v, IrCl3·3H2O, 2-
ethoxyethanol, 130 
o
C, followed by ligand 6 or 7, NEt3, acetylacetone, ethylene glycol, 190 
o
C.   
  
Scheme 2. Synthesis of complexes 23-25. Reagents and conditions: i, LDA, THF, -78 
o
C, I2, THF, 20 
o
C; ii, NaMeSO2 or Nap-TolSO2, CuI, DMF, 110 
o
C; iii, IrCl3·3H2O, 2-ethoxyethanol, 130 
o
C, 
followed by picolinic acid, 130 
o
C. 
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Scheme 3. Synthesis of complex 31. Reagents and conditions: i, n-BuLi, hexane, THF, -78 
o
C, 
triisopropyl borate, -78 
o
C to 20 
o
C, dilute HCl; ii, 2-chloro-4-mesitylpyridine, PPh3, DME, Na2CO3, 
Pd(OAc)2, reflux; iii, HCl, DCM/MeOH, RT; iv, mcpba, DCM, 20 
o
C, NaHSO3; v, [Ir(cod)Cl]2, 2-
ethoxyethanol, 130 
o
C, followed by picolinic acid, 130 
o
C. 
 
X-Ray Crystal Structures 
Single crystal X-ray structures were obtained for 10, 11·3CH2Cl2, 12·2.75CH2Cl2, 13·MeCN, 15· 
2CH2Cl2·0.85MeOH, 23·CH2Cl2 and 31·4CH2Cl2 (Figures 1, S1-S6 and Table S1).  A different 
polymorph of 11·3CH2Cl2 with essentially the same molecular geometry, has been reported previously 
by Fan et al.
35e
 In all the complexes, the Ir atom has slightly distorted octahedral coordination. Table 1 
lists bond lengths of all the structures with two C^N ligands and one N^O picolinate ligand.  
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Table 1. Selected bond distances (Å) 
 
 10 11 12 13 15 23 31 
Ir-N(1) 2.137(3) 2.134(3) 2.140(5) 2.128(3) 2.161(4) 2.129(4) 2.120(4) 
Ir-N(2) 2.027(3) 2.048(3) 2.033(5) 2.048(4)
 a
 2.032(4) 2.035(4) 2.031(4) 
Ir-N(3) 2.046(3) 2.029(3) 2.033(5) 2.040(4) 2.037(4) 2.041(4) 2.037(4) 
Ir-O(1) 2.146(2) 2.158(2) 2.133(4) 2.148(3) 2.151(3) 2.142(3) 2.145(4) 
Ir-C(7) 1.974(3) 1.985(3) 1.986(6) 1.994(4) 1.982(5) 1.987(4) 1.993(5) 
Ir-C(18) 1.991(4) 1.989(3) 2.000(6) 1.979(5)
 a
 1.989(5) 1.990(4) 1.998(4) 
a Weighted  average for the disordered ligands 
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Figure 1. X-ray molecular structures of 11-13 and 15. Minor disorder components, solvent of 
crystallization and all H atoms are omitted, thermal ellipsoids are drawn at the 50% probability level.  
 
The N atoms of the two C^N ligands are coordinated trans to each other.  The picolinate 
ligand, as well as oppy ligand in 15, forms a longer Ir-N bond, due to trans-effect of the ζ-bonded C 
atom.  In molecule 12, the methylsulfonyl and mesityl groups of one C^N ligand are both disordered 
between two orientations in a 0.55:0.45 ratio (the Mes by a flipping motion).  The Mes groups are 
 9 
nearly perpendicular to the adjacent Py rings, the dihedral angles being 86° for the ordered Mes group, 
82° and 73° for the disordered Mes groups. In structure 13, one whole C^N ligand is disordered 
between two orientations differing by a ca. 10° libration around the Ir atom, with occupancies refined 
to 0.684(5) and 0.316(5), respectively. All the chelating ligands show small but significant non-
planarity. In the picolinato ligand, the dihedral angle between the Py and carboxylate planes varies 
from 0.9° in 13 to 10.6° in 12. In the C^N ligands, the twists between the phenyl and pyridine rings are 
the highest in complex 23 (12.7° and 14.7°), in other complexes they vary from 2° to 11°. The 
oxyphenyl-pyridine moiety in 15 is much more twisted with the two aromatic rings forming an angle 
of 37°. 
 
Thermal, Photophysical and Electrochemical Properties.  
 The absorption and emission spectra of the complexes in dichloromethane solution are shown 
in Figures 2 and S7-10 and the data are listed in Table 2. The complexes show strong absorption bands 
in the 250-300 nm region derived from ligand-centered * transitions.17 Absorption bands with 
lower extinction coefficients in the range 350-450 nm are ascribed to singlet and triplet metal-to-ligand 
charge-transfer (
1
MLCT and 
3
MLCT) states, following literature precedents,
17
 and the calculations of 
Hay.
46
  Emission of the complexes is in the blue or blue-green region. The following trends in this 
series of complexes can be seen. 
 (i) Addition of the sulfone moiety results in a blue shift in emission λmax relative to FIrpic of ~10 nm. 
The identity of the R group in –SO2R (tolyl or methyl) has little effect on the optoelectronic properties. 
(ii) Exchanging a fluoro for a methoxy substituent results in a red shift of ~5 nm. Therefore, all of the 
mono-fluoro-mono-methoxy complexes (23-25) have bluer emission than FIrpic, while the dimethoxy-
sulfone complex 31 has a λmax and emission profile comparable to FIrpic. 
(iii) Addition of a mesityl group results in little change to λmax, as observed previously.
33
 
(iv) Introducing a second sulfone group (complex 13) results in a red shift in emission of 50 nm and a 
change in spectral profile, compared to FIrpic. There is literature precedent for a sulfone group 
inducing a red shift when introduced at the 4-position of the phenyl ring of ppy in a neutral iridium 
complex.
35b
 
(v) Emission from the N^O bonded complexes 14 and 15 is red-shifted by ca. 10 nm relative to their 
pic analogs (10 and 11). 
The photoluminescence quantum yield (PLQY) and lifetime data are stated in Table 2. The observed 
lifetimes (τP = 1.49 – 3.53 μs) and the spectral profiles are indicative of phosphorescence from a 
mixture of ligand-centered and MLCT excited states.
17,47 
The PL spectra of representative complex 24  
obtained at 80, 120, 160, 200 and 240 K in degassed 2-MeTHF (Figure S11) show the expected 
 10 
sharpening of the emission bands and a blue shift on cooling due to reduction in vibrations. This is 
consistent with a significant 
3
LC contribution to the excited state.
47
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Figure 2. Normalized absorption (in dichloromethane, left) and emission (in degassed 
dichloromethane, right) solution state spectra of complexes 1, 10, 13, 14 and 23. 
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Table 2. Photophysical data of the iridium complexes.  
 
Complex 
λmax
abs (ε) / nm (x103 M-1cm-1) 
[a]
 
λmax
em 
/  
nm 
[b] 
Stokes shift / 
cm
-1 [b,c] 
PLQY / 
ΦPL
[b,d]
 
τP /  
μs [b,e] 
1  
FIrpic 
277 (50.1), 301 (34.2), 304 
(32.6), 337 (13.8, sh), 357 (8.9, 
sh), 400 (6.2), 454 (0.8) 
468, 496, 531 
(sh) 
800 0.67 1.72 
10 
255 (88.6), 282 (67.2), 292 
(61.7), 371 (9.4), 401 (sh, 3.8), 
443 (0.6) 
455, 482, 511 
(sh) 
660 0.64 2.19 
11 
252 (123.7), 286 (90.4), 300 
(83.0), 331 (sh, 23.4), 373 
(11.3), 407 (sh, 4.7), 444 (0.8) 
457, 483, 515 
(sh) 
700 0.68 2.09 
12 
260 (100.4), 283 (76.4), 321 
(sh, 30.9), 374 (13.1), 401 (sh, 
5.0), 444 (0.9) 
457, 485, 517 
(sh) 
700 0.68 1.49 
13 
261 (89.1), 284 (80.2), 306 (b, 
52.8), 399 (8.2), 452 (4.9), 490 
(0.6) 
516, 536 1450 0.48 3.53 
14 
264 (95.5), 278 (85.1), 302 (sh, 
58.1), 364 (19.4), 382 (sh, 
15.9), 421 (sh, 4.3), 447 (1.3) 
466, 491, 530 
(sh) 
870 0.44 2.90 
15 
250 (sh, 143.2), 266 (sh, 98.7), 
290 (83.4), 312 (56.5), 368 
(19.6), 414 (sh, 6.7), 449 (1.4) 
469, 494, 534 
(sh) 
910 0.38 2.85 
23 
253, 264, 290, 319 (sh), 372, 
406 (sh) 
460, 489, 522 
(sh) 
530 0.55 2.67 
24 
255, 269, 291, 336 (sh), 376, 
402 (sh) 
461, 489, 523 
(sh) 
530 0.58 1.79 
25 
258 (sh), 271, 297, 307 (sh), 
339 (sh), 379 
464, 490, 524 
(sh) 
670 0.58 1.78 
31 
275, 291, 324 (sh), 381, 405 
(sh) 
474, 500, 536 
(sh) 
830 0.50 2.13 
a 
Data obtained in < 10 μM dichloromethane solutions at 20 oC. b Data obtained in degassed 
dichloromethane solution with excitation wavelength at 380 nm. 
c
 Energy difference between lowest 
energy excitation maxima and highest energy excitation maxima. 
d 
Measured relative to Ir(ppy)3 ΦPL = 
0.46 in degassed dichloromethane at 20 
o
C; estimated error ±5%. 
e 
Estimated error ±5%. 
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Table 3. Electrochemical and computed molecular orbital energy data of iridium complexes 
 
Complex 
 
E
ox
1/2  /  
V
[a]
 
Obs 
HOMO / 
V 
Complex 
Calc 
HOMO / 
eV 
Calc 
LUMO / 
eV
 
Calc 
HLG 
eV 
1 FIrpic 0.89[0.92 ref 16] -5.69 1’ -5.49 -1.87 3.62 
10 1.19 -5.99 10’ -6.09 -2.23 3.86 
11 1.16[1.21 ref 35e]  -5.96 11’ -5.97 -2.15 3.82 
12 1.15 -5.95 12’ -6.01 -2.15 3.86 
13 1.25 -6.05 13’ -6.15 -2.46 3.69 
14 
0.93 (irr), 1.62 
(irr)
[b]
 
-5.73 14’ -5.80 -2.20 3.60 
15 
0.94 (irr), 1.63 
(irr)
[b]
 
-5.74 15’ -5.61 -2.04 3.57 
23 1.02 -5.82 23’ -5.82 -2.06 3.76 
24 1.02 -5.82 24’ -5.74 -2.00 3.74 
25 1.01 -5.81 25’ -5.64 -1.94 3.70 
31 0.89 -5.69 31’ -5.53 -1.89 3.64 
a 
Redox data were obtained in 0.1 M NBu4PF6 acetonitrile solutions and are reported vs. FcH/FcH
+
.
48
 
b
 The values reported are the cathodic peak potentials observed on the first scan.  
 
 
 The thermal stabilities of the iridium complexes were evaluated using TGA under a nitrogen 
atmosphere. The 5% weight loss temperatures (Td), are above 360 
o
C for all complexes, and are 
comparable to FIrpic (370 
o
C), suggesting the complexes should be thermally stable under device 
operation (Table S2).     
The electrochemical properties of the complexes were examined by cyclic voltammetry (CV) 
in a 0.1 M NBu4PF6 acetonitrile solution. The observed reversible oxidation waves are assigned to the 
Ir(III)/Ir(IV) couple (Table 3, Figures 3 and S12).  All difluoro-sulfone pic complexes (10-12) show an 
increase in oxidation potential of ~0.28 V relative to that of FIrpic, indicating the sulfone group is 
effective at lowering the HOMO. Exchanging a fluorine for a methoxy group (23-25) results in a 
 13 
smaller increase in oxidation potential of ~0.13 V relative to FIrpic, and the dimethoxy-sulfone 
complex 31 has an oxidation potential comparable to that of FIrpic. If the LUMO energies are 
assumed to be very similar in these complexes, the relative HOMO energies from their CV data are 
consistent with the λmax values obtained from the emission spectra. The oxidation potential of 13 is 
+1.25 V, suggesting that addition of the second sulfone moiety lowers the HOMO; however, it must 
also lower the LUMO significantly, as the emission spectrum is strongly red shifted. Complexes 14 
and 15 both show two irreversible oxidation waves; if the scan is reversed before the second oxidation 
is reached the first oxidation wave is still irreversible. This suggests a chemical reaction takes place 
upon oxidation, and could be attributed to the unusual connectivity around the Ir centre. No additional 
ligand-centered oxidation waves were detected on scanning to +2.0 V for the pic complexes, and no 
reduction waves were observed on scanning between 0 and -2.0 V.  
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Figure 3. Cyclic voltammograms for representative complexes 1, 12-14, 24 and 31 
 
DFT Calculations. 
 Electronic structure calculations were carried out on the 11 iridium complexes studied here 
(including FIrpic 1) to explore the frontier orbitals and understand the nature of the transitions 
involved in the absorption and emission bands observed (Tables S3-S13). The full geometries of the 
iridium complexes were optimized at B3LYP/LANL2DZ:3-21G* and the optimized geometries are 
denoted as 1’, 10’-15’, 23’-25’ and 31’ to identify them as computed models and distinguish the 
predicted data from experimental data. Comparison between optimized and X-ray determined 
geometries reveal good agreement for the seven Ir bond distances with differences below 0.04 Å 
 14 
(Table S14). The complexes, 10’-12’, 23’-25’ and 31’, have orbital contributions broadly similar to 
FIrpic 1’ with the HOMO on iridium and phenyl (ppy) and the LUMO on the pyridyl of the picolinate 
ligand (Figure 4).  
The lower HOMO energies on the complexes containing the sulfonyl groups, compared to 
FIrpic, reflect the electron-withdrawing properties of the former. Frontier orbital energies are listed in 
Table 3 for direct comparison with observed CV data. The observed and computed HOMO energies 
are in very good agreement. The electron-donating methoxy groups in 23’-25’ increase the HOMO 
energies in 23’-25’ relative to 10’-12’. The electron-donating effect of the four methoxy groups in 31’ 
cancels the electron-withdrawing effect of the two sulfonyl groups, thus 31’ has remarkably similar 
orbital energies and distributions to FIrpic.  
The LUMOs in 10’-12’, however, do have substantial contributions from the pyridyl groups of 
the ppy ligands which lower their orbital energies compared to FIrpic. Nevertheless, the effect of the 
sulfonyl groups on the HOMO energies is larger than on the LUMO energies in complexes 10’-12’ 
and 23’-25’ compared to the FIrpic frontier orbitals. Therefore, the HOMO-LUMO energy gaps 
(HLGs) in these complexes are larger than the HLG in FIrpic and their emissions would be more blue-
shifted than FIrpic as observed experimentally. 
 Compound 13’ with four sulfonyl groups has a similar HOMO as the other iridium complexes 
discussed above, but its LUMO is located on the ppy ligand(s) not on the picolinate ligand. The 
different LUMO is due to the four electron-withdrawing sulfonyl groups on the ppy ligands which 
would be more easily reduced than the picolinate ligand. In 13’, the effect of the sulfonyl groups on 
the LUMO energy increases, thus its HLG energy is closer to that of FIrpic than of complexes 10’-12’. 
While the HOMO-LUMO gap for 13 is larger than expected, the TD-DFT prediction for 13 is 490 nm 
compared to 1 at 471 nm. Thus this supports the experimental observation that the low-energy 
absorption of 13 is red-shifted compared to 1. 
The HOMOs for the oppy-containing complexes, 14’ and 15’, are located at the oppy group 
bonded to iridium rather than on iridium and phenyl (ppy) as is the case for the HOMOs of the other 
complexes here. The different HOMOs result in higher HOMO energies compared to 10’-12’ and 
therefore 14’ and 15’ have the smallest HLG energies of all iridium complexes calculated here. The 
relatively high HOMO energies of 14’ and 15’ and different HOMOs to the other iridium complexes 
are reflected in the irreversible CV waves observed at lower oxidation potentials here. The LUMOs for 
14’ and 15’ are on the ppy ligands. 
 15 
  
Figure 4. Frontier molecular orbitals for 10’, 13’ and 14’. All contours are plotted at ±0.05 (e/bohr3)1/2. 
Ir : pic or oppy : ppy % orbital contribution ratio listed for each orbital. 
TD-DFT computations were carried out on the S0 optimized geometries of 1’, 10’-15’, 23’-25’ 
and 31’ to predict emission wavelengths of these iridium complexes. The initial excitation is assumed 
to give the lowest energy singlet excited state S1 which in the presence of the iridium results in 
intersystem crossing (ISC) to form the triplet excited state T1 and phosphorescence is observed from 
the S0 ← T1 process. The small Stokes shifts observed for most complexes suggest that the T1 
geometry is similar to the corresponding S0 geometry. The reverse process S0 ← T1 is thus considered 
to have the same nature as the computed S0 → T1 process with the predicted emission wavelength 
adjusted to take into account the Stokes shift.  
 Table 4 compares the predicted S0 ← T1 wavelengths with observed emission wavelengths for 
all iridium complexes where the agreement is excellent except for complexes 13’-15’. The emissions 
of complexes 13’-15’ are likely to be from different triplet excited state geometries as shown in their 
subtly lower PLQYs and longer lifetimes than the other iridium complexes, 1’, 10’-12’, 23’-25’ and 
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31’. In the case of 13, the larger Stokes shift observed suggests substantial rearrangement of the 
geometry in the T1 excited state. The emissions from 14 and 15 may be from different triplet excited 
states of higher energies via ISC as the HOMOs of 14’ and 15’ contain less iridium character (Table 4) 
and their S1 excited states may not result in ISC to the predicted T1 excited states.  
The emission intensities for FIrpic and 15 were recorded at different excitation wavelengths 
(10 nm intervals between 380 and 430 nm, Figures S8 and S9) to examine why the predicted T1 
excited state energies for 14 and 15 differ from the observed emission data. These measurements 
reveal a significant decrease in the emission intensities for 15 compared to those for FIrpic as the 
excitation wavelengths lengthen. The observed decrease implies a different ISC pathway in 15 
compared to FIrpic and thus a different triplet excited state in 15 to the predicted T1 state. 
 
Table 4. Iridium atom contributions in HOMOs and predicted (TD-DFT) emission wavelengths of 
iridium complexes. 
Complex 
% Ir  
HOMO 
% Ir  
HOMO-1 
S0 ← T1 
nm 
[a]
 
S0 ← T2 
nm 
[a]
 
Complex 
Observed λmax
em 
/  
nm 
[b]
 
1’ 44  471  1  471 
10’ 44  456  10 455 
11’ 42  458  11 457 
12’ 44  460  12 457 
13’ 44  490  13 516 
14’ 20 
[c]
 45  500 
[c]
 474 14 465 
15’ 21 
[c]
 38  503 
[c]
 472  15 468 
23’ 40  463  23 460 
24’ 41  467  24 461 
25’ 39  467  25 464 
31’ 40  473  31 474 
a 
Values from TD-DFT data on S0 optimized geometries with scaling energy factor of 0.945 based on 
dichloromethane at 298 K. 
b 
Observed highest energy band from emission spectra (Table 2).
 c
 
Observed emission is unlikely via ISC from S1 to T1 as this ISC pathway may not be promoted due to 
a smaller iridium contribution in the HOMO. Different triplet states with higher energies are assumed 
to be responsible for emissions of 14 and 15. 
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Optimized geometries at the T1 excited state for 10’, 13’ and 14’ were carried out to examine 
the differences in the T1 geometries compared to their corresponding optimized S0 geometries. From 
T1 vertical energies on both S0 and T1 geometries, the energy differences are 0.27, 0.30 and 0.28 eV 
for 10’, 13’ and 14’ respectively meaning that the T1 geometry differs (i.e. rearranges) from its S0 
geometry in 13’ more than in 10’ and 14’. These energy values support the larger Stokes shift energy 
observed (Table 2) for 13’ compared to the measured Stokes shift energies for all other iridium 
complexes.  
The spin densities at the iridium atom in the optimized T1 geometries for 10’, 13’ and 14’ are 
0.36, 0.46 and 0.13 respectively. The low spin density value of 0.13 for 14’ suggests that a different 
triplet excited state with higher energy is responsible for the phosphorescence in 14 and, by 
implication, 15. The emission wavelengths in 14 and 15 would therefore be shorter than the predicted 
S0 ← T1 emission wavelengths, as observed experimentally. The higher spin density at the iridium 
atom in the optimized T1 geometry for 13’ compared to that for 10’ may explain the less vibronic 
structure emission observed in 13 compared to that in 10. An increased vibronic structure in the 
observed emission usually means an increased ligand contribution (and decreased metal character) to 
the excited state.   
 
Phosphorescent Organic Light-emitting Devices 
 PhOLEDs were fabricated using FIrpic 1 and complexes 10-12, 23-25 as the dopant phosphor. 
Complexes 13-15 and 31 were not studied in devices as their PL spectra are red-shifted compared to 
the other analogs and our focus is on obtaining blue devices.  The device architecture comprised a 
simple single-emissive-layer which was a blend of poly(vinylcarbazole) (PVK) as the host material, 
OXD-7 (an electron-transporting material) and the Ir complex to give the architecture: 
ITO/PEDOT:PSS (45 nm)/PVK:OXD-7(35%):Ir complex(15%)(60 nm)/TPBi (30 nm)/LiF/Al. The 
emissive layer was spin-coated from chlorobenzene solution to avoid potential degradation of the 
complexes which can occur during thermal evaporation, especially for complexes with fluorinated 
ligands.
32
 An additional electron transporting layer of TPBi was incorporated adjacent to the cathode 
to optimize charge balance and confine excitons in the emitter layer.
49
 The efficiency and luminance 
data of the devices are summarized in Table 5. The electroluminescence (EL) spectra for FIrpic 1 and 
complexes 10-12, 23-25 are shown in Figure 5a. Several trends are apparent.  
(1) For all the complexes the EL and PL spectra are similar, indicating good exciton confinement on 
the emissive molecules.  
(2) The devices of 11, 12, 24 and 25 performed better than those of 10 and 23 both in terms of EQE 
and brightness (Figure 5, panels c and e). For 12, 24 and 25 this can be attributed to the presence of the 
mesityl group on the ppy ligands, which has been shown previously to enhance device performance.
33
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The increased solubility of 11 (p-tolylsulfonyl substituent) compared to 10 (methylsulfonyl analog) 
gave rise to better film quality for 11 which could explain its enhanced performance.  
(3) The FIrpic devices are the most efficient in this series. This can be explained by a superior trapping 
efficiency for the FIrpic device compared to the other complexes; the HOMO level of the PVK host is 
-5.8 eV, which aligns well with FIrpic (-5.69 eV, observed; -5.49 eV, calculated: Table 3).  However, 
the HOMO levels of complexes 10-12, 23-25 are equal to that of PVK or lower (Table 3), resulting in 
less efficient hole trapping. The lower efficiency for 10-12 and 23-25 is also consistent with the known 
trend that a rapid decline in efficiency is induced upon blue-shifting the emission color.
50
 
(4) We also note that the extent of the efficiency roll-off is directly proportional to the current density 
and brightness for most of the devices. Efficiency roll-off in OLED devices has been comprehensively 
discussed.
51
    
 The higher efficiency which is reproducible for complex 11 at ca. 1 mA/cm
2
 (Figure 5d) is 
typical of some OLEDs at the device turn-on due to a slight change in material morphological defects  
caused by the initial current passing through the device.
52
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Figure 5: Electroluminescence device data. Device architecture: ITO/PEDOT:PSS (45 
nm)/PVK:OXD-7(30%):Ir complex(15%)(60 nm)/TPBi (30 nm)/LiF/Al.   
 
Table 5. Summary of Device Luminescence and Efficiency Data. 
Complex λELmax  
/ nm 
brightness 
/ cd/m
2
 
Turn-
on 
voltage  
/ V
 a
 
EQE 
/ % 
current 
efficiency 
/ cd/A 
power 
efficiency 
/ lm/W 
CIE 
coordinates / 
(x,y)
b
 
1 475 7340 6.2 5.4 12.2 5.1 (0.19, 0.38) 
10 463 776 6.8 3.0 2.0 0.8 (0.19, 0.29) 
11 463 2464 8.0 3.9 8.2 2.9 (0.20, 0.36) 
12 465 2368 8.0 4.0 7.8 2.0 (0.18, 0.30) 
23 469 1772 8.1 3.0 5.9 2.1 (0.17, 0.33) 
24 469 2851 6.0 3.9 7.6 3.3 (0.17, 0.32) 
25 470 2072 8.5 3.5 6.1 1.9 (0.16, 0.30) 
 
 
a
 Measured at a brightness of 10 cd/m
2
. 
b
 Measured at 12 V. 
 
CONCLUSIONS 
In summary, a series of heteroleptic Ir complexes [Ir(ppy)2(pic)] has been synthesized with sulfonyl 
substituents attached to C3 of the phenyl ring of the ppy ligands. Compared to the benchmark sky-blue 
emitter FIrpic, the additional electron-withdrawing sulfonyl substituent results in a blue shift of the 
max of PL and EL by up to ca. 12 nm as a result of the increased HOMO-LUMO gap. Replacing a 
fluorine atom by a methoxy group red shifts the max of PL and EL by ca. 4-6 nm. Two complexes 
with an unusual 2-(2’-oxyphenyl)pyridyl ancillary ligand have been obtained by an in situ nucleophilic 
displacement of a fluorine substituent on a ppy ligand. (TD-)DFT calculations are in excellent 
agreement with the observed photophysical and electrochemical properties of the complexes. 
 20 
PhOLEDs have been fabricated using a selection of the complexes in a simple device architecture with 
a solution-processed single-emitting layer in the configuration ITO/PEDOT:PSS/PVK:OXD-
7(35%):Ir-Complex(15%)/TPBi/LiF/Al. The EL data confirm the potential of the new complexes to 
serve as blue dopants in functional devices with a notably lower CIE Cy coordinate, compared to 
FIrpic. The work provides further examples where the efficiency of blue PhOLEDs is enhanced by the 
presence of a mesityl substituent on the pyridyl ring of the ppy ligands.   
 
EXPERIMENTAL SECTION  
Materials, Synthesis and Characterization.  All commercially available chemicals were used 
without further purification. Reactions requiring an inert atmosphere were performed under a blanket 
of argon gas, which was dried over a phosphorus pentoxide column. Anhydrous solvents were dried 
through an HPLC column on an Innovative Technology Inc. solvent purification system.  Column 
chromatography was performed using 40-60 μm mesh silica gel. Analytical TLC was performed on 
plates pre-coated with silica gel (Merck, silica gel 60F254) and visualized using UV light (254, 315, 
365 nm). NMR spectra (Figures S13-34) were recorded on Bruker Avance 400 MHz, Varian Mercury 
200 and 400 MHz, Varian Inova 500 MHz or Varian VNMRS 600 and 700 MHz spectrometers. 
Chemical shifts are referenced to tetramethylsilane [TMS, Si(CH3)4] at 0.00 ppm. Melting points were 
determined in open ended capillaries using a Stuart Scientific SMP3 melting point apparatus at a 
ramping rate of 1 
o
C/min. They are recorded to the nearest 0.1 
o
C. ESI and MALDI mass spectra were 
recorded on a Thermo-Finnigan LTQ FT (7.0 T magnet) spectrometer. ASAP mass spectra were 
recorded on a Waters Xevo QTOF spectrometer. GCMS spectra were recorded on a Thermo-Finnigan 
Trace GCMS (EI and CI ion sources). Elemental analyses were obtained on an Exeter Analytical Inc. 
CE-440 elemental analyser. HPLC was performed on an analytical/semi-prep Varian LC system 
equipped with UV-vis and ES
+
 mass detectors. 
 Solution electrochemistry and photophysics. Cyclic voltammetry experiments were recorded 
using a BAS CV50W electrochemical analyzer fitted with a three-electrode system consisting of a Pt 
disk (Ø = 1.8 mm) as the working electrode, a Pt wire as an auxiliary electrode and an Ag/AgNO3 (0.1 
M[NEt4][ClO4] in CH3CN) system as the reference electrode. Experiments were conducted in dry 
acetonitrile solution with n-BuNPF6 (0.1 M) as the supporting electrolyte at a scan rate of 100 mV/s. 
The reference electrode was assumed to be stable and was referenced externally to ferrocene (Cp2Fe) 
and decamethylferrocene (Cp*2Fe) which displayed potentials (E1/2) of -0.41 V and +0.10 V, 
respectively, versus Ag/AgNO3 under these conditions. It was not possible to use Cp2Fe or Cp*2Fe as 
an internal reference because their addition to the solutions of the complexes resulted in a distortion of 
the redox waves of the complexes. 
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 Solution state photophysical data were obtained using freshly prepared solutions of the 
complexes in DCM. Emission and lifetime measurements used thoroughly degassed solutions 
achieved by three freeze-pump-thaw cycles, and quartz cuvettes with a path length of 1 cm. The 
solutions had absorbance below 0.10 to minimize inner filter effects. UV-vis absorption measurements 
were recorded using a Unicam UV2-100 spectrometer operated with Unicam Vision(ver. 3.50) 
software. Baseline correction was achieved by reference to pure solvent in the same cuvette. 
Absorption measurements were obtained using quartz cuvettes with a path length of 2 cm.  
Excitation and emission spectra were recorded on a Jobin-Yvon-Horiba SpexFluoromax 3 
Spectrometer. Solutions of the complexes in degassed DCM [<10
-5
 M] were used for decay 
measurements. Samples were excited with a pulsed Nitrogen laser emitting at 337.1 nm. Emission was 
focused onto a spectrograph and detected on a sensitive gated iCCD camera (Stanford Computer 
Optics) with sub-nano-second resolution. Solution PLQYs were recorded in degassed solvent, and 
determined using the relative method, with Ir(ppy)3 (ΦPL = 0.46 in degassed dichloromethane, 
determined in house vs, ΦPL = 0.546 in 0.5 M H2SO4) as the reference. The PLQYs were calculated 
according to the following equation: 
 
where subscripts ‘x’ and ‘ref’ denote the material being measured and the reference, respectively. Φ 
represents the PLQY, Grad is the gradient from the plot of integrated fluorescence intensity vs 
absorbance, and η is the refractive index of the solvent. 
 
Computational studies. All calculations were carried out with the Gaussian 09 package.
53
 All 
optimized S0 geometries were carried out using B3LYP
54
 with the pseudopotential (LANL2DZ)
 55
 for 
iridium and 3-21G* basis set for all other atoms.
56
 This model chemistry was selected on the basis of 
related computational studies on [Ir(ppy)2Cl]2
57
 and Ir(ppy)3.
58
 All S0 optimized geometries of the 
most stable conformers were true minima based on no imaginary frequencies found. Electronic 
structure and TD-DFT calculations were also from the optimized geometries at B3LYP/LANL2DZ:3-
21G*. The MO diagrams and orbital contributions were generated with the aid of Gabedit
59
 and 
GaussSum
60 
packages, respectively. The time-dependent DFT (TD-DFT) method does not include 
spin-orbit couplings thus no oscillation strengths for the triplet excited states are given and also does 
not compute mixed singlet-triplet excited states. Optimized triplet excited state (T1) geometries were 
also carried out on 10’, 13’ and 14’ to examine significant changes between their S0 and T1 geometries 
in order to explain the differences in observed and computed emission values for 13 and 14. Optimized 
triplet excited state (T1) geometries by TD-DFT can be considered unreliable
56
 so our interpretations 
are based on the assumption that these geometries are accurate.  
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 Phosphorescent Organic Light-emitting Devices (PhOLEDs). PhOLEDs were fabricated on 
indium tin oxide (ITO)-coated glass substrates of thickness 125 nm and possessing a sheet resistance 
of 15 Ω/. Poly(3,4-ethylenedioxythiophene) doped with high work function hole injection layer 
poly(styrenesulfonic acid) (PEDOT:PSS) (HIL1.3), from CLEVIOS™, was spin coated at 2500 rpm 
for 60 s to produce a ~50 nm thick hole-injecting/transporting layer (HTL). The PEDOT:PSS layer 
was annealed at ca. 200 
o
C for 5 min to remove any residual water. A chlorobenzene solution of 25 
mg/ml of poly(vinylcarbazole) (PVK) (Mw=90000) was doped with 30% w/w of (1,3-
phenylene)bis[5-(4-tert-butylphenyl)-1,3,4-oxadiazole] (OXD-7). Blended devices were made by 
mixing 15% w/w of the Ir complexes. The prepared mixtures were filtered with a 0.45 µm pore filter 
and spin coated at 2500 rpm for 1 min on the top of the PEDOT:PSS layer and baked for 10 min at 120 
o
C. Each sample was shadow masked to produce four identical devices of area 4 x 5 mm; the samples 
were then introduced into a nitrogen glove box, where 30 nm of 2,2′,2′′-(1,3,5-benzenetriyl)tris-[1-
phenyl-1H-benzimidazole] (TPBi) was evaporated as an electron injection /hole blocking layer at a 
rate of ~1 Å/s under vacuum at a pressure of ca. 1 x 10
-6
 torr, followed by 0.8 nm LiF and a 100 nm 
capping layer of aluminium under the same evaporation conditions. Therefore, the device 
configuration for all complexes was: ITO/PEDOT:PSS (50 nm)/PVK:OXD-7 (35%):Ir-Complex 
(15%)/TPBi (30 nm)/LiF(0.8 nm)/Al(100 nm). All samples were encapsulated inside a glove box 
using DELO UV cured epoxy (KATIOBOND) and capped with a 1.2 x 1.2 cm microscope glass slide 
then exposed to UV light for 3 min. Current–voltage data, device efficiency, brightness and 
electroluminescence spectra were measured in a calibrated Labsphere LMS-100 integrating sphere. A 
home written NI LabVIEW programme was used to control an Agilent 6632B DC power supply, and 
the emission properties of the device were measured using an Ocean Optics USB4000 CCD fibre optic 
spectrometer. Thicknesses of the various layers in the device were measured with a J A Woolam 
VASE Ellipsometer using thin films which had been spin coated on Si/SiO2 substrates under the same 
conditions as the device films. 
 
General procedure for ortho lithation followed by iodination: 
 
n
BuLi (1.2 eq.) was added to a stirred solution of DIPA (1.3 eq.) in dry THF at 0 
o
C and the solution 
was stirred for 30 min. The temperature was then lowered to -78 
o
C and a solution of the substrate (1 
eq.) in dry THF was added in portions via cannula and the mixture was stirred for a further 1 h. A 
solution of I2 (1.1-1.3 eq.) in dry THF was added to the flask dropwise. The solution was stirred at -78 
o
C and allowed to warm to room temperature overnight. The solution was then quenched with an 
aqueous solution of NaS2O3 to remove unreacted LDA and I2. The solution was then extracted with 
DCM (3 x 75 mL) and the organic phases combined, dried over MgSO4, filtered and the solvent was 
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reduced in vacuo. The residue was passed through a silica plug (eluent: DCM/ethyl acetate) to remove 
baseline impurities revealed by TLC. The solvent was removed and the crude product was either 
triturated with cold hexane, or purified by column chromatography, to remove any unreacted starting 
material. The product was then dried on a high vacuum line to leave the pure product. 
 
General procedure for sulfone synthesis: 
The iodo compound (1 eq.), the sodium sulfinate derivative (1.6 eq.) and CuI (1.5 eq.) were dissolved 
in dry DMF and stirred under argon. The mixture was heated at 110 
o
C overnight. The mixture was 
cooled to room temperature and water (20 mL) and DCM (20 mL) were added. The solid was filtered 
off and washed with more DCM. The organic layer was separated, dried over MgSO4 and the solvent 
was removed in vacuo. The residue was purified by column chromatography to give pure product, 
unless otherwise specified. This is in accordance with the method described in the literature.
38
  
 
General procedure for synthesis of iridium pic complexes: 
Method A: IrCl3.3H2O (1 eq.) was added to a stirred solution of the cyclometalating ligand (2.1-2.2 
eq.) in 2-ethoxyethanol. The mixture was heated to reflux at 130 
o
C under argon overnight. The 
mixture was then left to cool and the solvent was removed in vacuo. The yellow solid, presumed to be 
the intermediate bis(μ-Cl)dimer complex, was washed with cold hexane to remove any free ligand and 
dried. Where possible, the bis(μ-Cl) dimer was characterized by 1H NMR and mass spectrometry, 
although attempted purification usually led to decomposition. The dimer was then suspended in 2-
ethoxyethanol and picolinic acid (<3 eq.) was added. The mixture was stirred and heated to reflux (130 
o
C) under argon overnight. The mixture was allowed to cool to room temperature and the solvent was 
removed. The product was then purified by column chromatography to give pure product, unless 
otherwise specified. 
 
Method B: The reaction was conducted via a one-pot method and the intermediate bis(μ-Cl) dimer was 
not isolated.  
 
Synthesis of ligands and complexes 
2-(2,4-difluoro-3-iodophenyl)-4-(2,4,6-trimethylphenyl)pyridine (5). The reaction followed the general 
procedure for lithiation / iodination using 
n
BuLi (3.69 mL, 2.5 M), DIPA (1.40 mL, 9.99 mmol), 2-
(2,4-difluorophenyl)-4-(2,4,6-trimethylphenyl)pyridine 3
33a
 (2.38 g, 7.68 mmol), I2 (2.14 g, 8.43 
mmol) and THF (45 mL). The mixture was purified using a Biotage® Isolera One ™ purification 
system to give 5 as a white semi-solid (2.50 g, 75%); δH (400 MHz, CDCl3, Me4Si); 8.77 (1H, dd, J 
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5.0 0.9), 8.07 (1H, td, J 8.7 6.4), 7.59 (1H, dt, J 2.4 1.3), 7.12 (1H, dd, J 4.9 1.5), 7.05 (1H, ddd, J 8.6 
6.9 1.5), 6.98 (2H, s), 2.35 (3H, s), 2.06 (6H, s); δF (376 MHz, CDCl3, Me4Si) -90.98 (1F, q, J 5.7), -
93.59 – -93.67 (1F, m); δC (101 MHz, CDCl3, Me4Si) δC (101 MHz, CDCl3, Me4Si) 161.85 (dd, J 
249.4 5.4), 158.83 (dd, J 250.2, 5.9), 152.15 (d, J 3.4), 150.31, 150.07, 137.75, 136.13, 135.20, 132.31 
(dd, J 9.2, 4.2), 128.50, 125.50 (d, J 9.4), 124.46 (dd, J 14.4, 3.7), 123.96, 111.94 (d, J 3.7), 111.71 (d, 
J 3.7), 72.01 (dd, J 30.9, 29.3), 21.16, 20.71; HRMS (FTMS+ESI): calcd for [C20H16NF2I+H]
+
: 
436.0374. Found: 436.0378. 
2-[2,4-difluoro-3-(methanesulfonyl)phenyl]pyridine (6). Using the general procedure for sulfone 
synthesis the following reagents were used: 2-(2,4-difluoro-3-iodophenyl)pyridine 4
35e
 (1.00 g, 3.15 
mmol), sodium methanesulfinate (0.515 g, 5.05 mmol), copper iodide (0.90 g, 4.73 mmol), DMF (3 
mL). Purification by column chromatography (4% EtOAc in DCM, increased to 20% EtOAc in DCM) 
gave a product which was recrystallized from a mixture of hexane and DCM to give 6 as a white solid 
(0.133, 15%); m.pt. 95.2-97.0 
oC; δH (400 MHz; CDCl3; Me4Si) 8.72 (1H, dt, J 4.8 1.4), 8.27 (1H, td, 
8.6 6.0), 7.71-7.87 (2H, m), 7.32 (1H, ddd, J 6.7 4.8 2.1), 7.18 (1H, td, 9.2 1.6), 3.34 (3H, s); δF (376 
MHz, CDCl3, Me4Si) -106.14 (1F, dd, J 9.3 6.2), -111.50 (1F, d, J 8.3); δC (101 MHz, CDCl3, Me4Si) 
159.86 (dd, J 262.6 4.0), 157.50 (dd, J 262.6 3.9), 150.89, 150.18, 137.32 (dd, J 10.9 5.8), 136.90, 
125.80 (dd, J 13.7 4.1), 124.63 (d, J 9.5), 123.42, 118.55 (dd, J 17.3 15.5), 113.80 (dd, J 23.1 4.0), 
45.88 (t, J 2.4); HRMS (FTMS+ESI): calcd for [C12H9F2NO2S+H]
+
: 270.03948. Found: 270.03938. 
2-(2,4-difluoro-3-[(4-methylbenzene)sulfonyl]phenyl)pyridine (7). 2-(2,4-difluoro-3-
iodophenyl)pyridine 4 (2.17 g, 6.84 mmol), sodium p-toluenesulfinate (1.95 g, 10.94 mmol) and 
copper iodide (1.95 g, 10.23 mmol) were dissolved in DMF (10 mL) and stirred under argon. The 
mixture was heated at 110 
o
C overnight. Column chromatography (4% EtOAc in DCM) gave a 
product which was recrystallized from a hexane/DCM mixture to give 7 as white crystals (0.62 g, 
26%); 99.5-100.9 
oC; δH (400 MHz; CDCl3; Me4Si) 8.67-8.71 (1H, m), 8.18 (1H, td, J 8.6, 6.0), 7.98 
(2H, d, J  8.1), 7.70-7.81 (2H, m), 7.34 (2H, d, J  8.1) 7.29 (1H, ddd, J 6.7, 4.8, 2.1), 7.10 (1H, td, J 
9.2, 1.6), 2.42 (3H, s); δF (376 MHz; CDCl3; Me4Si) -106.13 (1F, dd, J 9.3, 6.0), -111.44 (1F, d, J 8.1); 
δC (176 MHz; CDCl3; Me4Si) 159.9 (dd, J  263.1, 3.8), 157.4 (dd, J  263.1, 3.5), 151.2, 150.1, 145.4, 
139.1, 137.0 (dd, J 10.9, 5.7), 136.8, 130.0, 128.0, 125.6 (dd, J  13.6, 4.3), 124.8, 124.7, 123.3, 119.9 
(t, J  15.9), 113.7 (dd, J  23.3, 3.8), 21.8; HRMS (FTMS+ESI): calcd for [C18H13F2NO3S+H]
+
: 
346.0713. Found: 346.0692. These data are consistent with the literature data for 7 prepared by a 
different route.
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2-(2,4-difluoro-3-[methanesulfonyl]phenyl)-4-(2,4,6-trimethylphenyl)pyridine (8). The reaction 
followed the general procedure for sulfone synthesis using 2-(2,4-difluoro-3-iodophenyl)-4-(2,4,6-
 25 
trimethylphenyl)pyridine 5 (657 mg, 1.51 mmol), sodium methanesulfinate (247 mg, 2.42 mmol), CuI 
(431 mg, 2.26 mmol) and DMF (3 ml). The product was purified by column chromatography (2.5% 
EtOAc in DCM, increased to 10% v/v) to give 8 as an off-white solid  (130 mg, 22%); m.pt. 74.6-77.5 
oC; δH (400 MHz; CDCl3; Me4Si) 8.77 (1H, d, J 5.0), 8.36 (1H, td, J 8.6 6.0), 7.58-7.64 (1H, m), 7.21 
(1H, td, J 9.0, 1.5), 7.13-7.17 (1H, m), 6.96 (2H, d, J 1.1), 3.33 (3H, s), 2.33 (3H, s), 2.03 (6H, s); δC 
(101 MHz, CDCl3, Me4Si) 159.81 (dd, J 262.6, 4.0), 157.46 (dd, J 262.0, 4.0), 156.18 (d, J 3.9), 
151.00 (d, J 2.1), 150.59 (s), 150.25 (s), 137.83 (s), 137.31 (dd, J 10.8, 5.7), 135.79 (s), 135.03 (s), 
128.47 (s), 125.96 – 125.56 (m), 124.43 (s), 118.54 (dd, J 17.6, 15.5), 113.77 (dd, J 23.1, 3.9), 45.79 
(t, J 2.4), 21.09 (s), 20.64 (s); δF (376 MHz, CDCl3, Me4Si) -106.14 (1F, dd, J 10.2, 8.6), -111.40 (1F, 
d, J 11.0); HRMS (FTMS+ESI): calcd for [C21H19F2NO2S+H]
+
: 388.1183. Found: 388.1170. 
2-(2-fluoro-3,4-di[methanesulfonyl]phenyl)pyridine (9). The reaction followed the general procedure 
for sulfone synthesis using 2-(2,4-difluoro-3-iodophenyl)pyridine 4 (which had not been rigorously 
purified and was presumed to be contaminated with iodine) (1.00 g, 3.15 mmol), sodium 
methanesulfinate (0.515 g, 5.05 mmol), CuI (0.90 g, 4.73 mmol), DMF (3 mL). The reaction was 
worked up as described in the general procedure, and the crude product mixture was subjected to 
column chromatography (1:2 EtOAc in DCM, increased to 1:1 v/v to elute the final fraction). 
1
H NMR 
analysis revealed a mixture of products. The mixture was columned for a second time (10% EtOAc in 
DCM) to give two white solid products, 2-(2,4-difluoro-3-[methanesulfonyl]phenyl)pyridine 6 (135 
mg, 16%) (identical with the sample above) and 2-(2-fluoro-3,4-di[methanesulfonyl]phenyl)pyridine 9 
(115 mg, 11%); m.pt. 194.0-198.1 
o
C; δH (400 MHz; CDCl3; Me4Si) 8.78 (1H, d, J 4.7), 8.46 (1H, dd, 
J 8.4 6.9), 8.28 (1H, dd, J 8.3 1.1), 7.83 – 7.91 (2H, m), 7.39 (1H, td, J 4.8, 2.4), 3.58 (3H, s), 3.49 
(3H, s); δF (376 MHz, CDCl3, Me4Si) -106.57 (1F, d, J 6.9); δc (101 MHz, CDCl3, Me4Si) 159.10 (d, J 
265.4), 150.49, 150.13 (d, J 1.8), 143.03, 137.01, 136.64 (d, J 5.2), 135.16 (d, J 15.3), 129.59 (d, J 
14.7), 128.15 (d, J 3.5), 125.20 (d, J 9.8), 124.34, 46.27, 45.28; HRMS (FTMS+ESI): calcd for 
[C13H12FNO4S2+H]
+
: 330.0270. Found: 330.0273. 
Iridium complex 10. 
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The reaction followed the general procedure for the synthesis of iridium pic complexes, Method A, 
using IrCl3.3H2O (107 mg, 0.30 mmol), 2-(2,4-difluoro-3-[methanesulfonyl]phenyl)pyridine 6 (180 
mg, 0.67 mmol), picolinic acid (154 mg, 1.25 mmol) and 2-ethoxyethanol (10 mL). Attempted 
purification of a small portion of the intermediate μ-dichloro dimer resulted in rapid decomposition 
under ambient conditions, so no characterization data were obtained. Purification by column 
chromatography (DCM:acetone, 1:1) gave 10 as a yellow solid (190 mg, 85%); Anal. Calc. for 
C30H20F4IrN3O6S2: C, 42.35; H, 2.37; N, 4.94. Found: C, 42.17; H, 2.23; N, 4.88; δH (700 MHz; 
CDCl3; Me4Si) 8.75 (1H, dt, J 5.8, 1.3, HD6), 8.39 (1H, d, J 8.4, HB3), 8.35 (1H, d, J 7.8, HA3), 8.34 
(1H, d, J 8.8, HD3), 8.04 (1H, td, J 7.8, 1.6, HA4), 7.93 (1H, td, J 6.4, 1.6, HB4), 7.91 (1H, td, J 6.4, 1.7, 
HD4), 7.75 (1H, dt, J 5.1, 1.4, HA6), 7.54 (1H, ddd, J 7.8, 5.4, 1.5, HA5), 7.45 (1H, dd, J 5.7, 1.4, HB6), 
7.35 (1H, ddd, J 7.3, 5.8, 1.4, HD5), 7.14 (1H, ddd, J 7.4, 5.8, 1.4, HB5), 5.97 (1H, d, J 10.0, HE6), 5.73 
(1H, d, J 10.1, HC6), 3.27 (3H, s, HE7), 3.21 (3H, s, HC7); δF (376 MHz, CDCl3, Me4Si) -105.12 (1F, d, 
9.8), -106.30 (1F, d, 10.0), -109.57 (1F, s), -110.28 (1F, s); δC (176 MHz; CDCl3; Me4Si) 172.36 (s, 
CA7), 164.19 (d, J 6.8,CB2), 162.97 (d, J 6.4, CD2), 161.34 (d, J 8.1, CC2), 160.60 (d, J 8.5, CE2), 159.66 
(dd, J 268.2, 2.82, CE5),  159.19 (dd, J 266.4, 3.0, CC5), 157.54 (dd, J 271.1, 3.50, CE3), 157.33 (dd, J 
270.0, 4.5, CC3), 151.11 (s, CA2), 148.89 (s, CD6), 148.41 (s, CB6), 148.32 (s, CA6), 139.58 (s, CB/D4), 
139.57 (s, CB/D4), 139.46 (s, CA4), 130.10 (m, CC1), 129.92 (m, CE1), 129.18 (s, CA3/5), 129.11 (s, 
CA3/5), 124.49 (d, J 21.8, CB3), 124.21 (s, CD5), 124.14 (s, CB5), 124.00 (d, J 20.6, CD3), 116.64 (d, J 
19.3, CE6), 116.45 (d, J 19.1, CC6),111.83 (t, J 16.6, CC4), 111.22 (t, J 16.5, CE4), 45.94 (s, CC7/E7), 
45.90 (s, CC7/E7); HRMS (FTMS+ESI): calcd for [C30H20F4N3O6S2
191
Ir+H]
+
: 850.0414. Found: 
850.0439. Crystals for X-ray analysis were grown by slow evaporation of a DCM solution of 10. 
 
Iridium complex 11. The reaction followed the general procedure for synthesis of iridium pic 
complexes, Method A, using IrCl3.3H2O (278 mg, 0.79 mmol), 2-(2,4-difluoro-3-[(4-
methylbenzene)sulfonyl]phenyl)pyridine 7 (600 mg, 1.78 mmol), 2-ethoxyethanol (20 mL) to give the 
intermediate μ-dichloro dimer as a yellow solid (700 mg, 96%); δH (400 MHz; CDCl3; Me4Si) 8.91 
(4H, dd, J  6.2, 1.4), 8.35 (4H, d, J  8.5), 7.88-7.94 (4H, m), 7.83 (8H, d, J  8.1), 7.24 (8H, d, J  8.5), 
 27 
6.87 (4H, ddd, J  7.4, 5.8, 1.4), 5.24 (4H, d, J  10.6), 2.36 (12H, s); δF (376 MHz; CDCl3; Me4Si) -
105.27 (4F, d, J  10.4), -109.88 (4F, s); HRMS (FTMS+ESI): calcd for 
[C72H48Cl2F8
191
Ir2N4O8S4+Na2]
2+
: 939.0320. Found: 939.0303. The reaction proceeded as described in 
the general Method A using Ir dimer (500 mg, 0.27 mmol), picolinic acid (336 mg, 2.73 mmol), 2-
ethoxyethanol (10 mL). The reaction was worked up as previously described, and the product was 
purified by column chromatography (THF/DCM, 3:7 v/v), followed by recrystallization from 
DCM/hexane to give 11 as a yellow solid (421 mg, 77%). Anal. Calc. for C42H28F4IrN3O6S2: C 50.29; 
H 2.81; N 4.19. Found: C 50.03; H 2.96; N 4.01; δH (400 MHz; acetone-d6, Me4Si) 8.65 (1H, dt, J  5.7, 
1.1), 8.37 (2H, t, J  8.3), 8.19–8.07 (4H, m), 7.94 (1H, d, J  5.2), 7.87 (4H, t, J  7.6), 7.80 (1H, d, J  
5.8), 7.62 (1H, ddd, J  6.6, 5.4, 2.6), 7.55 (1H, ddd, J  7.4, 5.8, 1.4), 7.43-7.34 (5H, m), 6.01 (1H, d, J  
10.7), 5.70 (1H, d, J  10.6), 2.41 (3H, s), 2.40 (3H, s); δF (376 MHz; acetone-d6; Me4Si) -107.87 (1F, 
dd, J  10.7, 4.1), -108.61 (1F, dd, J  10.6, 3.6), -110.89 (1F, s), -111.59 (1F, s); HRMS (FTMS+ESI): 
calcd for [C42H28O6N3F4
191
IrS2+Na]
+
: 1026.0883. Found: 1026.0870. These data are consistent with 
the literature data for 11 prepared by a different route.
35e
 Crystals for X-ray analysis were grown by 
slow evaporation of a DCM/hexane solution of 11. 
Iridium complex 12. The reaction followed the general procedure for synthesis of iridium pic 
complexes, Method A, using IrCl3.3H2O (40 mg, 0.11 mmol), 2-(2,4-difluoro-3-
[methanesulfonyl]phenyl)-4-(2,4,6-trimethylphenyl)pyridine 8 (90 mg, 0.232 mmol), 2-ethoxyethanol 
(6 mL) to give the intermediate μ-dichloro dimer as a yellow solid. The NMR spectra were consistent 
with the dimer structure: δH (400 MHz; CDCl3; Me4Si) 9.52 (4H, d, J 5.9), 8.23 (4H, s), 6.97-7.05 
(12H, m), 5.34 (4H, d, J 10.8), 3.18 (3H, s), 2.40 (3H, s), 2.11 (3H, s), 2.07 (3H, s); δF (376 MHz, 
CDCl3, Me4Si) -105.73 (4F, d, J 12.0), -110.17 (4F, s). The reaction was continued as described in the 
general Method A using Ir dimer, picolinic acid (90 mg, 0.731 mmol) and 2-ethoxyethanol (6 mL). 
The product was purified by column chromatography (EtOAc:DCM 3:7 v/v) to afford Ir complex 12 
as a yellow solid (105 mg, 85%); Anal. Calc. for C48H40F4IrN3O6S2.0.5CH2Cl2: C, 51.57; H, 3.66; N, 
3.72. Found: C, 51.32; H, 3.62; N, 3.69; δH (400 MHz; CDCl3; Me4Si) 8.82 (1H, dd, J 6.0 0.7), 8.40 – 
8.48 (1H, m), 8.21 (1H, t, J 1.7), 8.15  (1H, t, J 1.7), 8.09 (1H, td, J 7.8 1.6), 7.89 (1H, ddd, J 5.4 1.6 
0.8), 7.60 (1H, ddd, J 7.8 5.3 1.5), 7.50 (1H, dd, J 6.0 0.7), 7.21 (1H, dd, J 5.9 1.7), 6.95 – 7.04 (5H, 
m), 5.94 (1H, d, J 10.3), 5.73 (1H, d, J 10.4), 3.25 (3H, s), 3.20 (3H, s), 2.35 (6H, s), 2.12 (3H, s), 2.09 
(6H, s), 1.96 (3H, s); δF (376 MHz, CDCl3, Me4Si) -105.58 (1F, dd, J 10.9 3.5), -106.77 (1F, dd, J 11.4 
3.3), -109.82 (1F, d, J 4.1), -110.61; HRMS (FTMS+ESI): calcd for [C48H40F4N3O6S2
191
Ir + H]
+
: 
1086.1979. Found: 1086.1978.  Crystals for X-ray analysis were grown by slow evaporation of a 
DCM/hexane solution of 12. 
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Iridium complex 13. The reaction followed the general procedure for synthesis of iridium pic 
complexes, Method A, using IrCl3.3H2O (94 mg, 0.27 mmol), 2-(2-fluoro-3,4-
bis(methylsulfonyl)phenyl)pyridine 9 (194 mg, 0.59 mmol), and 2-ethoxyethanol (8 mL) to give an 
orange-yellow solid presumed to be the bis(μ-Cl)dimer, which was used without further purification. 
Due to its very poor solubility NMR data could not be obtained. The reaction was continued as 
described in the general Method A using picolinic acid (245 mg, 1.99 mmol), 2-ethoxyethanol (8 mL). 
The product was purified by column chromatography (DCM:acetone 1:1 v/v) to give 13 as a yellow 
solid (208 mg, 80%); Anal. Calc. for C32H26F2IrN3O10S4: C, 39.58; H, 2.70; N, 4.33. Found: C, 39.42; 
H, 2.61; N, 4.42; δH (400 MHz; CDCl3; Me4Si); 8.85 (1H, d, J 5.2), 8.52 (1H, d, J 8.6), 8.48 (1H, d, J 
8.6), 8.36 (1H, d, J 7.5), 7.97-8.10 (3H, m), 7.70 (1H, d, J 5.2), 7.62 (1H, d, J 6.0), 7.57 (1H, t, J 6.4), 
7.49 (1H, t, J 6.4), 7.29 (1H, t, J 6.6), 7.14 (1H, s), 6.83 (1H, s), 3.43 (3H, s), 3.41 (3H, s), 3.37 (3H, 
s), 3.36 (3H, s); δF (376 MHz, CDCl3, Me4Si) -105.51 (1F, s), -106.32 (1F, s); HRMS (FTMS+ESI): 
calcd for [C32H26F2N3O10S4
191
Ir+H]
+
: 970.0153. Found: 970.0177. Crystals for X-ray analysis were 
grown by slow evaporation of a DCM/acetonitrile solution of 13. 
Iridium complex 14. 
 
IrCl3.3H2O (69 mg, 0.20 mmol) was added to a stirred solution of 2-(2,4-difluoro-3-
[methanesulfonyl]phenyl)pyridine 6 (116 mg, 0.67 mmol) in 2-ethoxyethanol (8 mL). The mixture 
was heated to reflux at 130 
o
C under argon overnight. The mixture was then left to cool and the solvent 
was removed in vacuo to give a yellow solid, presumed to be the bis(μ-Cl)dimer, which was used 
without further purification. The dimer was dissolved in ethylene glycol (8 mL) and 2-(2,4-difluoro-3-
[methanesulfonyl]phenyl)pyridine 6 (58 mg, 0.22 mmol), NEt3 (0.1 mL) and acetylacetone (0.1 mL) 
were added. The mixture was stirred under argon and heated to reflux at 190 
o
C overnight. The 
mixture was then left to cool. DCM (25 mL) and water (25 mL) were added and the organic layer was 
separated and washed with water (2 x 60 mL) to remove most of the ethylene glycol. The solvent was 
removed in vacuo to leave a brown liquid residue which was washed with water (5 mL) to remove any 
residual ethylene glycol. The residue was then purified by column chromatography (DCM/methanol 
 29 
29:1 followed by DCM:EtOAc 4:1 v/v) to give iridium complex 14 as a yellow solid (56 mg, 29%); δH 
(700 MHz; CD2Cl2; Me4Si) 9.03 (1H, ddd, J 5.7, 1.7, 0.8, HA6), 8.49 (1H, d, J 8.5, HA3), 8.27 (1H, d, J 
8.5, HC3), 8.10 (1H, ddd, J 5.7, 1.7, 0.8, HC6), 8.00 (1H, td, J 8.0, 7.4, 1.6, HA4), 7.85 (1H, ddd, J 8.2, 
7.4, 1.7, HE4), 7.82 (1H, ddd, J 8.4, 7.6, 1.6, HC4), 7.73 (1H, dd, J 8.0, 1.1, HE3), 7.52 (1H, dd, J 8.8, 
6.0, HF3), 7.47 (1H, ddd, J 5.7, 1.7, 0.8, HE6), 7.35 (1H, ddd, J 7.3, 5.7, 1.4, HA5), 6.98 (1H, ddd, J 7.4, 
5.8, 1.4, HC5), 6.96 (1H, ddd, J 7.4, 5.8, 1.4, HE5), 6.33 (1H, dd, J 10.6, 8.8, HF4), 5.93 (1H, d, J 10.5, 
HB6), 5.71 (1H, d, J 10.5, HD6), 3.20 (3H, s, HB/D7), 3.19 (3H, s, HB/D7), 2.74 (3H, s, HF7); δF (376 
MHz, CDCl3, Me4Si) -105.39 (1F, dd, J 10.1, 6.2), -105.70 (1F, dd, J 10.1, 2.8), -106.70 (1F, dd, J 9.9, 
2.6), -109.10 (1F, s), -109.94 (1F, s); δC (176 MHz, CDCl3, Me4Si) 167.68 (CF1), 163.85 (CC2), 162.72 
(CA2), 162.45 (CF5), 159.03 (CB5, J 262.5), 158.33 (CD5, J 272.9), 155.38 (CE2), 150.91 (CC6), 150.41 
(CE6), 149.08 (CA6), 139.94 (CA4), 139.68 (CC4), 139. 53 (CE4), 136.07 (CF3), 131.78 (CD1), 130.56 
(CB1), 125.92 (CE3), 125.71 (CF2), 124.98 (C A3), 124.51 (CC3), 124.26 (CA5), 123.82 (CE5), 123.19 
(CC5), 120.95 (CF6), 117.23 (CB6, d, J 18.1), 116.46 (CD6, d, J 17.8), 104.60 (CF4, d, J 24.1), 46.33 
(CB+D7), 45.49 (CF7); HRMS (FTMS+ESI): calcd for [C36H25F5N3O7S3
191
Ir+H]
+
: 994.0459. Found: 
994.0478.  
 
Iridium complex 15. IrCl3.3H2O (136 mg, 0.39 mmol) was added to a stirred solution of 2-(2,4-
difluoro-3-[(4-methylbenzene)sulfonyl]phenyl)pyridine 7 (293 mg, 0.85 mmol) in 2-ethoxyethanol (10 
mL). The mixture was heated to reflux at 130 
o
C under argon overnight. The mixture was then left to 
cool and the solvent was removed in vacuo to leave a yellow solid, presumed to be the bis(μ-Cl)dimer, 
which was used without further purification. The dimer was dissolved in ethylene glycol (8 mL) and 
the 2-(2,4-difluoro-3-[(4-methylbenzene)sulfonyl]phenyl)pyridine 7 (130 mg, 0.38 mmol), NEt3 (0.1 
mL) and acetylacetone (0.1 mL) were added. The reaction procedure and work-up as described for 14 
gave iridium complex 15 as a yellow solid (110 mg, 23%); Anal. Calc. for C54H37N3F5O7S3Ir: C, 
53.11; H, 2.89; N, 3.44. Found: C, 52.64; H, 2.89; N, 3.37; δH (400 MHz; CDCl3; Me4Si) 8.36 (1H, d, 
J 8.5), 8.25 (1H, d, J 8.5), 7.93 (3H, dd, J 6.3, 1.8), 7.89 – 7.78 (4H, m), 7.71 (2H, tdd, J 8.1, 6.2, 1.7), 
7.62 – 7.55 (1H, m), 7.42 (1H, dd, J 8.9, 6.0), 7.36 – 7.26 (3H, m), 7.15 – 7.05 (2H, m), 6.99 – 6.91 
(2H, m), 6.91 – 6.76 (5H, m), 6.28 (1H, dd, J 10.4, 8.8), 5.92 (1H, d, J 10.3), 5.40 (1H, d, J 10.6), 2.41 
(3H, s), 2.37 (3H, s), 2.19 (3H, s); δF (376 MHz; CDCl3; Me4Si) -105.11 – -105.21 (2F, m), -108.21 
(1F, dd, J 10.7, 3.1), -108.35 (1F, d, J 4.3), -108.90 – -108.97 (1F, m); HRMS (FTMS+ESI): calcd for 
[C54H37F5N3O7S3
191
Ir+H]
+
: 1222.13925. Found: 1222.13928. Crystals for X-ray analysis were grown 
by slow evaporation of a solution of 15 in DCM/hexane/MeOH (1:2:1 v/v) at room temperature. 
 
2-(2-fluoro-4-methoxyphenyl)-pyridine) (16).  A solution of 2-fluoro-4-methoxyphenylboronic acid 
(1.00 g, 5.88 mmol) and 2-bromopyridine (0.62 mL, 6.46 mmol) in dioxane (30 mL)  was degassed by 
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bubbling argon for 30 min. An aqueous solution of  Na2CO3 (0.79 g, 7.44 mmol in 4 mL) was added, 
followed by Pd(PPh3)4 (70 mg, 0.06 mmol). The mixture was heated to 95 
o
C overnight under argon, 
then allowed to cool and the solvent was removed in vacuo. Water and DCM were added and the 
organic layer was separated. The aqueous layer was extracted with more DCM, dried over MgSO4 and 
the solvent was removed in vacuo. The crude oil was purified by distillation using a Kuglerohr 
apparatus. Residual 2-bromopyridine distilled first (70-80 
o
C, 0.75 mbar), followed at 115 
o
C, 0.75 
mbar by 2-(2-fluoro-4-methoxyphenyl)-pyridine) 16 as a pale yellow oil (1.09 g, 91%);  δH (400 MHz; 
CDCl3; Me4Si) 8.68 (1H, ddd, J 4.8, 1.8, 1.0), 7.95 (1H, t, J 9.0), 7.67-7.77 (2H, m), 7.18 (1H, ddd, J 
7.0, 4.9, 1.5), 6.81 (1H, ddd, J 8.8, 2.5, 0.7), 6.69 (1H, dd, J 13.2, 2.5), 3.83 (3H,s); δF (376 MHz, 
CDCl3, Me4Si) -114.74 (1F, t, J 12.3); δC (101 MHz; CDCl3; Me4Si) 161.47 (d, JC-F 11.2), 161.32 (d, 
JC-F 249.5), 153.43 (d, JC-F 2.8), 149.68 (s), 136.40 (s), 131.63 (d, JC-F 4.9), 124.03 (d, JC-F 9.8), 121.85 
(s), 120.01 (d, JC-F 11.9), 110.65 (d, JC-F 2.9), 102.00 (d, JC-F 27.0), 55.72 (s); HRMS (FTMS+ESI): 
calcd for [C12H10NFO+H]
+
: 204.0825. Found: 204.0817. 
2-(2-fluoro-4-methoxyphenyl)-4-mesitylpyridine (17). A solution of 2-chloro-4-(2,4,6-
trimethylphenyl)pyridine
33a
 (1.23 g, 5.31 mmol), 2-fluoro-4-methoxyphenylboronic acid (1.00 g, 5.88 
mmol), palladium(II) acetate (73 mg, 0.36 mmol) and triphenylphosphine (363 mg, 1.52 mmol) in 1,2-
dimethoxyethane (60 mL) was degassed with argon for 30 min. A 2 M aqueous solution of sodium 
carbonate (11 mL, 2.31 g, 24.01 mmol) was degassed for 25 min. The solutions were combined and 
the mixture was heated to reflux (105 
o
C) under argon for 24 h. The reaction mixture was then cooled 
to room temperature and the DME was removed in vacuo. DCM (50 mL) was then added, followed by 
brine (50 mL). The organic layer was separated and dried over MgSO4. The solvent was removed in 
vacuo and the residue was purified by column chromatography (EtOAc:hexane 1:5 v/v) to give 2-(2-
fluoro-4-methoxyphenyl)-4-mesitylpyridine 17 as a yellow oil (1.35 g, 78%); δH (400 MHz; CDCl3; 
Me4Si) 8.73 (1H, dd, J 4.9, 0.9), 8.02 (1H, t, J 9.0), 7.55-7.61 (1H, m), 7.03 (1H, dd, J 5.0, 1.5), 6.94-
6.99 (2H, m), 6.84 (1H, ddd, J 8.8, 2.5, 0.7), 6.69 (1H, dd, J 13.1, 2.5), 3.85 (3H, s), 2.34 (3H, s), 2.05 
(6H, s); δF (376 MHz, CDCl3, Me4Si) -114.38 (1F, t, J 13.2); δC (101 MHz; CDCl3; Me4Si ) 161.28 (d, 
J 250.1), 161.41 (d, J 11.4), 153.50 (d, J 2.8), 149.79 (s), 149.69 (s), 137.48 (s), 136.51 (s), 135.28 (s), 
131.59 (d, J 4.8), 128.33 (s), 125.00 (d, J 9.8), 122.86 (s), 119.95 (d, J 11.6), 110.58 (d, J 3.0), 101.93 
(d, J 27.2), 55.67 (s), 21.05 (s), 20.62 (s); HRMS (FTMS+ESI): calcd for [C21H20FNO+H]
+
: 322.1607. 
Found: 322.1608. 
2-(2-fluoro-3-iodo-4-(methoxyphenyl)-pyridine) (18). The reaction used the general procedure for 
lithiation followed by iodination using 
n
BuLi (1.94 mL, 2.5 M), DIPA (0.75 mL, 5.34 mmol), 2-(2-
fluoro-4-methoxyphenyl)-pyridine) 16 (790 mg, 3.89 mmol), I2 (1.38 g, 5.44 mmol) and THF (35 mL). 
Purification by column chromatography (hexane:EtOAc 3:2 v/v) gave 2-(2-fluoro-3-iodo-4-
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methoxyphenyl)-pyridine) 18 (746 mg, 58%) as an off-white solid; m.pt. 107.2-109.7 
oC; δH (400 
MHz; CDCl3 Me4Si) 8.69 (1H, dt, J 4.8, 1.5), 7.98 (1H, t, J 8.8), 7.71-7.78 (2H, m), 7.19-7.28 (1H, 
m), 6.76 (1H, dd, J 8.8, 1.2), 3.96 (3H, s); δF (376 MHz; CDCl3; Me4Si) -93.14 (d, J 10.7); δC (101 
MHz; CDCl3 Me4Si) 160.09 (d, J 248.0), 160.33 (d, J 6.1), 152.82 (d, J 3.3), 149.79, 136.62, 131.84 
(d, J 4.8), 124.23 (d, J 9.6), 122.33, 121.25 (d, J 14.9), 106.97 (d, J 2.9), 75.06 (d, J 28.96), 57.02; 
HRMS (FTMS+ESI): calcd for [C12H9NFOI+H]
+
: 329.9791. Found: 329.9787.  
2-(2-fluoro-3-iodo-4-methoxyphenyl)-4-(2,4,6-trimethylphenyl)pyridine (19). The general procedure 
for lithiation followed by iodination used 
n
BuLi (2.1 ml, 2.5 M), DIPA (0.81 ml, 5.78 mmol), 2-(2-
fluoro-4-methoxyphenyl)-4-mesitylpyridine 17 (1.35 g, 4.20 mmol), I2 (1.49 g, 8.09 mmol) and THF 
(30 ml, dry). The reaction was worked up as described in the general method, and the product was then 
purified by column chromatography (hexane:EtOAc 2:1) to give an off-white solid, 2-(2-fluoro-3-
iodo-4-methoxyphenyl)-4-mestitylpyridine) 19 (1.03 g, 55%); m.pt. 167.4-168.5 
o
C; δH (400 MHz; 
CDCl3; Me4Si) 8.73 (1H, dd, J 5.0, 0.9), 8.05 (1H, t, J 8.8), 7.54-7.61 (1H, m), 7.06 (1H, dd, J 5.0, 
1.5), 6.96 (2H, s), 6.78 (1H, dd, J 8.8, 1.1), 3.97 (3H, s), 2.34 (3H, s), 2.05 (6H, s); δF (376 MHz, 
CDCl3, Me4Si) -92.81 (d, J 12.6); δC (101 MHz; CDCl3; Me4Si)  159.98 (d, J 248.3), 160.21 (d, J 6.1), 
152.81 (d, J 3.3), 150.05, 149.76, 137.55, 136.27, 135.17, 131.73 (d, J 4.9), 128.34, 125.21 (d, J 9.7), 
123.27, 121.17 (d, J 14.5), 106.83 (d, J 2.9), 74.96, 56.88, 21.05, 20.62; HRMS (FTMS+ESI): calcd 
for [C21H19NFOI+H]+: 448.0574. Found: 448.0565. 
2-(2-fluoro-4-methoxy-3-(methylsulfonyl)phenyl)pyridine (20). The reaction followed the general 
procedure for sulfone synthesis using 2-(2-fluoro-3-iodo-4-methoxyphenyl)-pyridine) 18 (1.02 g, 3.11 
mmol), CuI (0.89 g, 4.67 mmol), MeSO2Na (0.51 g, 4.98 mmol) in DMF (2.5 mL). The product was 
purified by column chromatography (DCM:EtOAc 1:1 v/v) to give 2-(2-fluoro-4-methoxy-3-
(methylsulfonyl)phenyl)pyridine 20 (390 mg, 45%); δH (400 MHz; CDCl3; Me4Si) 8.70 (1H, dt, J 4.8, 
1.4), 8.23 (1H, dd, J 9.0, 8.3), 7.72-7.82 (2H, m), 7.26-7.30 (1H, m), 6.98 (1H, dd, J 8.9, 1.3), 4.03 
(3H, s), 3.34 (3H, s); δF (376 MHz; CDCl3; Me4Si) -113.56 (d, J 9.3); δC (176 MHz; CDCl3; Me4Si) 
159.07 (d, J 3.4), 158.4 (d, J 263.2), 151.87 (d, J 1.7), 149.96, 136.87 (d, J 6.1), 136.72, 124.60 (d, J 
9.8), 122.80, 122.20 (d, J 14.3), 118.01 (d, J 13.6), 108.66 (d, J 3.5), 57.28, 45.61; HRMS 
(FTMS+ESI): calcd for [C13H12NFO3S+H]
+
: 282.0600. Found: 282.0615. 
2-(2-fluoro-4-methoxy-3-[methylsulfonyl]phenyl)-4-(2,4,6-trimethylphenyl)pyridine (21). The reaction 
followed the general procedure for sulfone synthesis using 2-(2-fluoro-3-iodo-4-methoxyphenyl)-4-
mestitylpyridine) 19 (1.00 g, 2.24 mmol), CuI (0.68 g, 3.58 mmol) and MeSO2Na (0.34 g, 3.35 mmol) 
and DMF (3.5 ml, dry). The reaction was worked up as described in the general procedure, and the 
product was purified by column chromatography (DCM:EtOAc 1:1) to give 2-(2-fluoro-4-methoxy-3-
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(methylsulfonyl)phenyl)-4-mesitylpyridine 21 (470 mg, 53%); m.pt. 169.2 -170.8 
o
C; (400 MHz; 
CDCl3; Me4Si) 8.74 (1H, d, J 5.0), 8.30 (1H, t, J 8.6), 7.57-7.63 (1H, m), 7.10 (1H, dd, J 5.0, 1.5), 
7.00 (1H, dd, J 9.0, 1.2), 6.92-6.97 (2H, m), 4.05 (3H, s), 3.32 (3H, s), 2.33 (3H, s), 2.03 (6H, s); δF 
(376 MHz; CDCl3; Me4Si) -113.44 (d, J 9.5); δC (176 MHz; CDCl3; Me4Si) 159.09 (d, J 3.3), 158.49 
(d, J 263.0), 152.00, 150.46, 150.07, 137.77, 136.91 (d, J 5.9), 136.11, 135.17, 128.49, 125.72 (d, J 
8.9), 123.89, 122.24 (d, J 14.0), 118.06 (d, J 13.3), 108.68 (d, J 3.4), 57.29, 45.61, 21.18, 20.74; 
HRMS (FTMS+ESI): calcd for [C22H22NFO3S+H]
+
: 400.1383. Found: 400.1379. 
 
2-(2-fluoro-4-methoxy-3-(p-toluenesulfonyl)phenyl)-4-mesitylpyridine (22). The reaction followed the 
general procedure for sulfone synthesis using 2-(2-fluoro-3-iodo-4-methoxyphenyl)-4-mesitylpyridine 
19 (0.81 g, 1.81 mmol), sodium p-tolylsulfinate (0.52 g, 2.90 mmol), CuI (0.52 g, 2.71 mmol) and 
DMF (3 mL). The product was purified by column chromatography (5% EtOAc in DCM, increased to 
20%) to give 2-(2-fluoro-4-methoxy-3-(p-toluenesulfonyl)phenyl)-4-mesitylpyridine 22 as an off 
white solid (0.17 g, 21%); δH (400 MHz; CDCl3; Me4Si)  8.73 (1H, dd, J 5.0, 0.9), 8.22 (1H, dd, J 8.9, 
8.2), 7.88-7.98 (2H, m), 7.56-7.66 (1H, m), 7.26-7.33 (2H, m), 7.08 (1H, dd, J 5.0, 1.5), 6.94-6.99 
(2H, m), 6.87 (1H, dd, J 9.0, 1.2), 3.85 (3H, s), 2.41 (3H, s), 2.34 (3H, s) 2.04 (6H, s); δF (376 MHz; 
CDCl3; Me4Si) -112.69 (1F, d, J 10.9); δC (101 MHz; CDCl3; Me4Si) 158.40 (d, J 263.0), 158.98 (d, J 
3.3), 152.10 (d, J 1.8), 150.26, 149.88, 144.17, 139.92, 137.63, 136.68 (d, J 6.1), 136.05, 135.10, 
129.26, 128.36, 127.82, 125.62 (d, J 9.9), 123.64, 121.78 (d, J 14.2), 118.64 (d, J 13.4), 108.61 (d, J 
3.6), 56.77, 21.65, 21.07, 20.64; HRMS (FTMS+ESI): calcd for [C28H26NFO3S+H]
+
: 476.1696. 
Found:  476.1718. 
 
Iridium complex 23. 
 
The reaction followed the general procedure for the synthesis of iridium pic complexes, Method B, 
using IrCl3.3H2O (233 mg, 0.66 mmol), 2-(2-fluoro-4-methoxy-3-(methylsulfonyl)phenyl)pyridine 20 
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(390 mg, 1.39 mmol), picolinic acid (284 mg, 2.31 mmol), 2-ethoxyethanol (12 mL). Purification by 
column chromatography (5% MeOH in DCM) gave a yellow solid which was suspended in ethanol 
and heated to reflux. The solution was filtered to afford complex 23 as a yellow solid (310 mg, 54%); 
Anal. Calc. for C32H26N3F2O8S2Ir: C, 43.93; H, 3.00; N, 4.80. Found: C, 44.02; H, 3.26; N, 4.97; δH 
(700 MHz; CDCl3; Me4Si) 8.78 (1H, ddd, J 5.8, 1.7, 0.8, HA6), 8.37 (1H, ddd, J 7.8, 1.5, 0.8, HE3), 
8.34 (1H, d, J 8.5, HB3),  8.27 (1H, d, J 8.5, HA3), 8.02 (1H, td, J 7.8, 1.6, HE4), 7.84 (1H, td, HB4) 7.82 
(1H, td, J, HA4), 7.79 (1H, ddd, J, HE6), 7.52 (1H, ddd, J 7.7, 5.4, 1.5, HE5), 7.46 (1H, ddd, J 5.9, 1.6, 
0.8, HB6), 7.23 (1H, ddd, J 7.3, 5.8, 1.4, HA5), 7.03 (1H, ddd, J 7.4, 5.8, 1.4, HB5), 5.73 (1H, s, HC6), 
5.57 (1H, s, HD6), 3.56 (3H, s, HC8), 3.51 (3H, s, HD8), 3.25 (3H, s, HC7), 3.20 (3H, s, HD7); δF (376 
MHz; CDCl3; Me4Si) -112.10 (1F, s), -112.58 (1F, s); δC (176 MHz; CDCl3; Me4Si) 172.31 (s, CE7), 
165.37 (d, J 6.2, CB2), 164.21 (d, J 6.2, CA2), 161.38 (CC/D2), 160.56 (CC/D2), 158.69 (d, J 3.0, CC5), 
158.40 (d, J 284.0, CC3), 158.30 (d, J 284.0, CD3), 158.18 (d, J 2.6, CD5), 151.18 (s, CE2), 148.64 (s, 
CA6), 148.26 (s, CE6), 148.00 (s, CB6), 138.90(s, CE4), 138.73 (s, CA/B4), 138.70 (s, CA/B4), 128.81 (s, 
CE3), 128.78 (s, CE5), 126.12 (d, J,CC1), 125.81 (d, CD1), 123.53 (d, J, CB3), 122.96 (d, J, CA3), 122.41 
(s, CB5), 122.35 (s, CA5), 111.28 (d, J 11.4, CD4), 111.01 (CD6), 110.93 (d, J 11.5, CC4), 110.73 (CC6), 
56.09 (s, CC8), 55.97 (s, CD8), 45.29 (s, CC/D7), 45.28 (s, CC/D7); HRMS (FTMS+ESI): calcd for 
[C32H26N3F2O8S2
191
Ir+H]
+
: 874.0814. Found: 874.0786. Crystals for X-ray analysis were grown by 
slow vapor diffusion of pentane into a solution of 23 in DCM. 
 
Iridium complex 24. The reaction followed the general procedure for the synthesis of iridium pic 
complexes, Method B, using IrCl3.3H2O (189 mg, 0.54 mmol), 2-(2-fluoro-4-methoxy-3-
(methylsulfonyl)phenyl)-4-mesitylpyridine 21 (450 mg, 1.13 mmol), picolinic acid (231 mg, 1.88 
mmol) and 2-ethoxyethanol (20 mL). The reaction was worked up as described in the general 
procedure and the residue was purified by column chromatography (5% MeOH in DCM). The yellow 
solid was suspended in ethanol and heated to reflux. The solution was filtered hot to afford Ir complex 
24 as a yellow solid (420 mg, 70%). Anal. Calc. for C50H46N3F2O8S2Ir·CH2Cl2: C, 51.21; H, 4.04; N, 
3.51. Found: C, 51.34; H, 3.99; N, 3.55; δH (400 MHz; CDCl3; Me4Si) 8.80-8.87 (m, 1H), 8.44 (1H, dt, 
J 7.8, 0.9), 8.19 (1H, s), 8.12 (1H, s), 8.07 (1H, td, J 7.7, 1.5), 7.88 (1H, dt, J 5.1, 1.3), 7.57 (1H, ddd, 
J 7.6, 5.3, 1.5), 7.45 (1H, d, J 5.9), 7.09 (1H, dd, J 5.9, 1.8), 6.93-7.02 (4H, m), 6.87 (1H, dd, J 5.9, 
1.8), 5.83 (1H, s), 5.77 (1H, s), 3.61 (3H, s), 3.58 (3H, s), 3.23 (3H, s), 3.19 (3H, s), 2.34 (6H, s), 2.09 
(3H, s), 2.05 (3H, s), 2.00 (3H, s), 1.95 (3H, s); δF (376 MHz; CDCl3; Me4Si) -111.68 (s), -112.28 (s);  
HRMS (FTMS+ESI): calcd for [C50H46N3F2O8S2
191
Ir+H]
+
: 1110.2379. Found: 1110.2393.  
 
Iridium complex 25. The reaction followed the general procedure for the synthesis of iridium pic 
complexes, Method B, using IrCl3.3H2O (72 mg, 0.20 mmol), 2-(2-fluoro-4-methoxy-3-(p-
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toluenesulfonyl)phenyl)-4-mesitylpyridine 22 (184 mg, 0.42 mmol), picolinic acid (37 mg, 0.30 mmol) 
and 2-ethoxyethanol (5 mL). The product was purified initially by column chromatography (EtOAc in 
DCM 1:4, increased to 1:3 v/v) to give a yellow solid which was further purified by recrystallization 
from ethanol to give complex 25 (210 mg, 83%); Anal. Calc. for C62H54N3F2O8S2Ir: C, 58.94; H, 4.31; 
N, 3.33. Found: C, 58.60; H, 4.26; N, 3.27; δH (400 MHz; CDCl3; Me4Si) 8.74 (1H, d, J 5.8), 8.39 
(1H, d, J 7.8), 8.15 (1H, s), 8.08 (1H, s), 8.04 (1H, td, J 7.7, 1.6), 7.85-7.90 (2H, m) 7.77-7.85 (3H, m), 
7.56 (1H, ddd, J 7.4, 5.3, 1.1), 7.40 (1H, d, J 5.9), 7.30 – 7.20 (4H, m), 7.03 – 6.92 (5H, m), 6.81 (1H, 
dd, J 5.9, 1.8), 5.71 (1H, s), 5.63 (1H, s), 3.43 (3H, s), 3.37 (3H, s), 2.38 (6H, s), 2.34 (6H, s), 2.08 
(3H, s), 2.00 (3H, s), 1.96 (3H, s), 1.94 (3H, s); δF (376 MHz; CDCl3; Me4Si)  -110.60 (1F, s), -111.33 
(1F, s);  HRMS (FTMS+ESI): calcd for [C62H54N3F2O8S2
191
Ir+H]
+
: 1262.3005. Found: 1262.3020.    
 (2,4-dimethoxy-3-(methylthio)phenyl)boronic acid  27. 
n
BuLi (11.25 mL, 2.5 M in hexanes) was 
added dropwise to a stirred solution of 3-bromo-2,6-dimethoxythioanisole 26
42
 (6.17 g, 23.45 mmol) 
in THF (15 mL, dry)  at -78 
o
C. The mixture was stirred at -78 
o
C for 1 h. Triisopropylborate (8.11 
mL, 35.15 mmol) was slowly added, and the reaction mixture was stirred at -78 
o
C for 1 h before being 
left to warm to room temperature overnight. Dilute HCl was added and the solution was extracted with 
EtOAc. The solvent was removed in vacuo to leave a sticky brown solid which was redissolved in 
EtOAc and was extracted with aqueous KOH (150 mL). The aqueous layer was acidified to pH 5 with 
dilute HCl and extracted with EtOAc. The solvent was removed in vacuo to give a beige solid, (2,4-
dimethoxy-3-(methylthio)phenyl)boronic acid 27 (2.80 g, 52%); δH (400 MHz; CDCl3; Me4Si) 7.80 
(1H, d, J 8.4), 6.79 (1H, d, J 8.4), 5.88 (2H, br s), 3.98 (3H, s), 3.97 (3H, s), 2.42 (3H, s); δB (128 
MHz; CDCl3; Me4Si) 28.66 (1B, br s); HRMS (FTMS+ESI): calcd for [C9H13O4S
10
B+H]
+
: 228.0742. 
Found:  228.0732. 
 
2-(2,4-dimethoxy-3-(methylthio)phenyl)-4-mesitylpyridine 28. 2-chloro-4-mesitylpyridine (0.72 g, 3.11 
mmol), (2,4-dimethoxy-3-(methylthio)phenyl)boronic acid 27 (0.85 g, 3.73 mmol) and PPh3 (211 mg, 
0.80 mmol) were dissolved in DME (50 mL) and the solution was degased for 20 min by bubbling 
with argon. An aqueous solution of Na2CO3 (1.34 g, 12.64 mmol in 10 mL) was degassed for 20 min. 
The solutions were combined and Pd(OAc)2 (43 mg, 0.19 mmol) was added. The mixture was heated 
to reflux for 24 h before being cooled. The solvent was removed under reduced pressure and DCM and 
water were added. The organic layer was separated, and the aqueous layer was extracted with further 
DCM. The extracts were combined and the solvent removed. The residue was purified by column 
chromatography (DCM:EtOAc 1:1 v/v) to give a white solid, 2-(2,4-dimethoxy-3-
(methylthio)phenyl)-4-mesitylpyridine 28 (0.70 g, 60%); m.pt. 133.4-136.2; δH (400 MHz; CD3OD; 
Me4Si) 8.65 (1H, dd, J 5.1, 0.9), 7.62 (1H, d, J 8.6), 7.58 – 7.52 (1H, m), 7.16 (1H, dd, J 5.1, 1.6), 6.97 
 35 
(2H, s), 6.97 (1H, d, J 8.7), 3.94 (3 H, s), 3.57 (3 H, s), 2.39 (3H, s), 2.31 (3H, s), 2.05 (6H, s); δC 
13
C 
NMR (101 MHz, CD3OD; Me4Si) 161.38, 159.22, 156.10, 150.69, 148.72, 137.40, 136.03, 134.50, 
130.81, 127.99, 126.57, 126.07, 123.18, 119.02, 107.31, 99.99, 19.73, 19.34, 16.60; HRMS 
(FTMS+ESI): calcd for [C23H25NFO2S+H]
+
: 380.1684. Found:  380.1666. 
 
2-(2,4-dimethoxy-3-(methylthio)phenyl)-4-mesitylpyridinium chloride 29.  HCl (0.05 mL, 12 M) was 
added to a stirred solution of 2-(2,4-dimethoxy-3-(methylthio)phenyl)-4-mesitylpyridine 28 (236 mg, 
0.62 mmol) in DCM/MeOH (40 ml, 1:1), and the mixture was stirred at RT overnight. The solvent was 
removed in vacuo to leave the product as a white solid, 2-(2,4-dimethoxy-3-(methylthio)phenyl)-4-
mesitylpyridinium chloride 29 (259 mg, 100%); m.pt. 177.3-180.2 
oC; δH (400 MHz; CD3OD; Me4Si) 
8.84 (1H, d, J 6.1), 8.18 – 8.12 (m, 1H), 7.87 (1H, dd, J 6.1, 1.9), 7.74 (1H, dd, J 8.8, 0.9), 7.12 (1H, d, 
J 8.8), 7.09-7.08 (2H, m), 4.03 (s, 3H), 3.75 (s, 3H), 2.47 (s, 3H), 2.37 (s, 3H), 2.14 (s, 6H);
 δC (176 
MHz, CD3OD; Me4Si) 164.17, 160.76, 159.45, 150.20, 140.89, 139.28, 134.22, 133.75, 130.94, 
128.91, 128.51, 126.27, 120.38, 117.78, 109.99, 108.05, 99.79, 60.89, 55.66, 22.77, 19.71, 19.16, 
16.28. 
 
2-(2,4-dimethoxy-3-(methylsulfonyl)phenyl)-4-mesitylpyridine 30. m-chloroperoxybenzoic acid (436 
mg,  2.68 mmol) was added to a stirred solution of 2-(2,4-dimethoxy-3-(methylthio)phenyl)-4-
mesitylpyridinium chloride 29 (510 mg,  1.22 mmol) in DCM (20 mL). The solution was stirred at 
room temperature overnight. The reaction was quenched with aqueous NaHSO3 and the organic layer 
was separated. The aqueous layer was extracted with additional DCM. The organic layers were then 
washed with aq. NaOH before the solvent was removed in vacuo and the residue was purified by 
reverse phase column chromatography (water/MeOH) to give a white solid, 2-(2,4-dimethoxy-3-
(methylsulfonyl)phenyl)-4-mesitylpyridine 30 (420 mg, 83%); m.pt. 155.8-160.8 
o
C, started to 
discolour at 148.7
 oC; δH (400 MHz; CDCl3; Me4Si) 8.75 (1H, dd, J 5.0, 0.9), 8.05 (1H, d, J 8.9), 7.70 
(1H, dd, J 1.6, 0.9), 7.09 (1H, dd, J 5.0, 1.6), 6.98 (1H, d, J 8.9), 6.96 (2 H, s), 4.00 (3 H, s), 3.61 (3 H, 
s), 3.33 (3 H, s), 2.33 (3 H, s), 2.03 (6 H, s); δC (101 MHz, CDCl3, Me4Si) 158.95, 158.44, 154.71, 
150.38, 149.99, 137.74, 137.21, 136.22, 135.07, 128.45, 128.14, 125.69, 123.55, 123.44, 109.10, 
63.42, 56.97, 46.25, 21.16, 20.74; HRMS (FTMS+ESI): calcd for [C23H25NFO4S+H]
+
: 412.1583. 
Found:  412.1564. 
 
Iridium complex 31. [Ir(cod)Cl]2 (51 mg, 0.19 mmol) was added to a stirred solution of 2-(2,4-
dimethoxy-3-(methylsulfonyl)phenyl)-4-mesitylpyridine 30 (130 mg, 0.32 mmol) in 2-ethoxyethanol 
(5 mL). The solution was heated to 130 
o
C under argon overnight, picolinic acid (26 mg, 0.21 mmol) 
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was added and the solution was heated at 130 
o
C for 6 h under argon. The solution was cooled and the 
solvent was removed in vacuo. The residue was purified by column chromatography (DCM/CH3CN 
2:1 v/v) to give a yellow solid, iridium complex 31 (70 mg, 40%); Anal. Calc. for C52H52N3O10S2Ir·1.5 
CH2Cl2: C, 50.89; H, 4.37; N, 3.33. Found: C, 50.43; H, 3.97; N, 3.08; δH (400 MHz; CDCl3; Me4Si) 
8.84 (1H, d, J), 8.50 (1H, dd, J 1.8, 0.7 Hz), 8.45 (1H, d, J 7.7), 8.37 (1H, dd, J 1.8, 0.7), 8.04 (1H, td, 
J 7.8, 1.6), 7.84 (1H, d, J 5.3), 7.53 (1H, ddd, J 7.4, 5.4, 1.5),  7.45 (1H, d, J 5.9), 7.05 (1H, dd, J  5.9, 
1.9), 7.04 – 6.96 (4H, m), 6.81 (1H, dd, J 5.9, 1.9), 5.83 (1H, s), 5.78 (1H, s), 3.92 (3H, s), 3.89 (3H, 
s), 3.55 (3H, s), 3.54 (3H, s),  3.25 (3H, s), 3.20 (3H, s), 2.35 (6H, s), 2.11 (3H, s), 2.05 (3H, s), 2.00 
(3H, s), 1.96 (3H, s); HRMS (FTMS+ESI): calcd for [C52H52N3O10S2
191
Ir+H]
+
: 1134.2778. Found: 
1134.2792. Crystals for X-ray analysis were grown by slow evaporation from a DCM/hexane mixture. 
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Table of Contents Graphic and Synopsis 
 
 
A series of heteroleptic Ir complexes [Ir(ppy)2(pic)] has been synthesized with sulfonyl substituents 
attached to the phenyl ring of the ppy ligands. The sulfonyl substituent leads to a significant blue shift 
of the max of photoluminescence and electroluminescence as a result of the increased HOMO-LUMO 
gap. 
 
